N-CSR

December 21, 2022

/s/ Joel P. Fried

Joel P. Fried

Co-Chief Executive Officer

0001193125-22-311695.txt : 20221223 0001193125-22-311695.hdr.sgml : 20221223 20221223133033 ACCESSION NUMBER: 0001193125-22-311695 CONFORMED SUBMISSION TYPE: N-CSR PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221223 DATE AS OF CHANGE: 20221223 EFFECTIVENESS DATE: 20221223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRIMECAP Odyssey Funds CENTRAL INDEX KEY: 0001293967 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CSR SEC ACT: 1940 Act SEC FILE NUMBER: 811-21597 FILM NUMBER: 221484678 BUSINESS ADDRESS: STREET 1: 177 EAST COLORADO BOULEVARD, 11TH FLOOR CITY: PASADENA STATE: CA ZIP: 91105 BUSINESS PHONE: 626-304-9222 MAIL ADDRESS: STREET 1: 177 EAST COLORADO BOULEVARD, 11TH FLOOR CITY: PASADENA STATE: CA ZIP: 91105 FORMER COMPANY: FORMER CONFORMED NAME: PRIMECAP Management Co DATE OF NAME CHANGE: 20160621 FORMER COMPANY: FORMER CONFORMED NAME: PRIMECAP Odyssey Funds DATE OF NAME CHANGE: 20040629 FORMER COMPANY: FORMER CONFORMED NAME: PRIMECAP Funds DATE OF NAME CHANGE: 20040616

0001293967 S000005539 PRIMECAP Odyssey Stock Fund

C000015069 PRIMECAP Odyssey Stock Fund POSKX

0001293967 S000005540 PRIMECAP Odyssey Growth Fund

C000015070 PRIMECAP Odyssey Growth Fund POGRX

0001293967 S000005541 PRIMECAP Odyssey Aggressive Growth Fund

C000015071 PRIMECAP Odyssey Aggressive Growth Fund POAGX

N-CSR 1 d419919dncsr.htm N-CSR N-CSR

As filed with the Securities and Exchange Commission on December 23, 2022

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-21597

PRIMECAP Odyssey Funds

(Exact name of registrant as specified in charter)

177 East Colorado Boulevard, 11^th Floor

Pasadena, CA 91105

(Address of principal executive offices) (Zip code)

Michael J. Ricks

PRIMECAP Management Company

177 East Colorado Boulevard, 11^th Floor

Pasadena, CA 91105

(Name and address of agent for service)

(626) 304-9222

Registrant’s telephone number, including area code

Date of fiscal year end: October 31

Date of reporting period: October 31, 2022

Item 1. Reports to Stockholders.

Item 1. Reports to Stockholders.

ANNUAL REPORT

For the Year Ended October 31, 2022

LOGO

PRIMECAP ODYSSEY STOCK (POSKX)

PRIMECAP ODYSSEY GROWTH (POGRX)

PRIMECAP ODYSSEY AGGRESSIVE GROWTH (POAGX)

Table of Contents

PRIMECAP Odyssey Funds


Letter to Shareholders			2

Performance Graphs			10

PRIMECAP Odyssey Stock Fund			10

PRIMECAP Odyssey Growth Fund			11

PRIMECAP Odyssey Aggressive Growth Fund			12

Sector Breakdown			13

Schedule of Investments			15

PRIMECAP Odyssey Stock Fund			15

PRIMECAP Odyssey Growth Fund			20

PRIMECAP Odyssey Aggressive Growth Fund			26

Statements of Assets and Liabilities			34

Statements of Operations			35

Statements of Changes in Net Assets			36

PRIMECAP Odyssey Stock Fund			36

PRIMECAP Odyssey Growth Fund			37

PRIMECAP Odyssey Aggressive Growth Fund			38

Financial Highlights			39

PRIMECAP Odyssey Stock Fund			39

PRIMECAP Odyssey Growth Fund			40

PRIMECAP Odyssey Aggressive Growth Fund			41

Notes to Financial Statements			42

Report of Independent Registered Public Accounting Firm			51

Expense Example			52

Additional Information			54

Management			60

Privacy Notice

Letter to Shareholders

PRIMECAP Odyssey Funds

Dear Fellow Shareholders,

For the fiscal year ended October 31, 2022, the PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund produced total returns of -11.33%, -17.61%, and -28.21%, respectively. The unmanaged S&P 500^® Index produced a total return of -14.61% during the period. Sector allocation benefited results relative to the S&P 500^®, while the impact from stock selection varied widely by Fund.

The fiscal year marked an abrupt degradation in market conditions. The year began with a disruptive bout of COVID-19, courtesy of the contagious omicron variant that peaked in mid-January. But in this case the prognosis was mostly good news, and thereafter Covid’s inordinate societal influence largely faded.

Geopolitical hostility and widespread inflation, however, supplanted COVID-19 as fresh sources of market anxiety. Russia’s invasion-turned-quagmire in Ukraine devastated the region and posed substantial risks to Europe and the world. Meanwhile, at home, stimulus-driven excess demand continued to overwhelm structurally-impaired supply chains and an inadequate labor pool; in other words, too much money chased too few goods (and services). Inflation thus broadened and worsened during the period, notching 40-year highs, as price spikes in goods and commodities hemorrhaged into stickier categories, like wages and services.

The Federal Reserve (the “Fed,”) chagrined by its earlier complacency in the face of ramping inflation, executed a dramatic hawkish pivot, punctuated by an ongoing series of aggressive rate hikes. The real economy stalled somewhat; despite solid nominal economic growth and a tight labor market, real gross domestic product declined during the first half of 2022. Yet the Fed resolved to further reduce economic activity, raising the prospects of a hard landing.

Equities unsurprisingly faltered amid this tumult, plummeting more than 25 percent from their January peak to their October lows before staging a late rally. Elevated inflation and rising interest rates weighed especially on high-valuation growth stocks; the communication services (-41%), consumer discretionary (-29%), and information technology (-20%) sectors lagged the market. Energy (+65%) fared best, a repeat of last fiscal year’s accolade, boosted by yet higher oil prices. Defensive sectors also generally outperformed, including consumer staples (+5%), utilities (+3%), and health care (+1%).

The Funds again endured a mixed relative report card, with only the Stock Fund eclipsing the benchmark. This divergent performance persisted from April’s half-year results, and it echoed last year’s rank ordering, as well. For two consecutive years, value stocks have outpaced growth stocks, with the gap widening substantially this fiscal year. Indeed, consistent with our semiannual commentary, the Growth and Aggressive Growth Funds outperformed size-specific, growth-centric indices for the full year despite trailing the broader market.

The Funds’ sector positioning continues to evolve, with information technology now a very modest underweight position in the Aggressive Growth Fund, a new development; the Stock and

Letter to Shareholders

PRIMECAP Odyssey Funds

continued

Growth Funds had already expressed an underweight view. Otherwise, each of the Funds held an overweight position in the health care and industrials sectors, and an underweight position in the energy, real estate, consumer staples, communication services, materials, and utilities sectors. The Growth Fund was also underweight the financials and consumer discretionary sectors; of these, the Stock Fund was overweight financials while the Aggressive Growth Fund was overweight consumer discretionary.

A more detailed discussion of the results of each PRIMECAP Odyssey Fund follows.

PRIMECAP Odyssey Stock Fund

For the fiscal year ended October 31, 2022, the Stock Fund’s total return of -11.33% exceeded the S&P 500^®’s total return of -14.61%. Relative to the S&P 500^®, sector allocation and stock selection both provided tailwinds to Fund performance.

All three Odyssey Funds benefited from favorable sector allocation, albeit to different degrees. The Stock Fund was the best-positioned Fund, owing chiefly to its more limited exposure to communication services (3% of average Stock Fund assets versus 9% for the index), the worst-performing sector, and a more substantial industrials overweight position (18% versus 8%). As with the other Funds, the Stock Fund also benefited from a large overweight position in health care (24% versus 14%) and a modest cash position (4%). Partially offsetting these exposures were underweight positions in the three best-performing sectors, energy (2% versus 4%), consumer staples (1% versus 6%), and utilities (0% versus 3%).

The Stock Fund also generated favorable stock selection results, in contrast to the Growth and Aggressive Growth Funds. Health care was a primary differentiator, as the Stock Fund’s greater concentration in large-capitalization biopharmaceuticals fared better than its peer Funds’ outsized ownership of smaller-capitalization biotechnology stocks. Eli Lilly (+44%) delivered another stellar performance on the back of its new diabetes and obesity drug, Mounjaro; the stock finished the period as the largest investment in all three Funds, but the Stock Fund position was most pronounced. Complementing Eli Lilly were four additional Top 10 holdings from the health care sector: two pharmaceutical companies (Bristol-Myers Squibb +37% and Astrazeneca -3%) and two biotechnology giants (Amgen +35% and Biogen +6%).

Stock selection elsewhere was more mixed. All three Funds largely avoided Meta (-71%) and Netflix (-58%) in communication services, while the Stock Fund’s distinctly smaller position in Alphabet (-36%) provided an additional relative boost. Within consumer discretionary, no exposure to Amazon (-39%) and limited ownership of Tesla (-39%) roughly offset disappointing performances from CarMax (-54%) and Sony (-41%). Within information technology, slumping PC demand doomed Intel (-40%) while no ownership in heavyweight Apple (+3%) also hurt; this combined headwind more than offset a strong year from Flex (+16%). Finally, Raymond James (+21%) and AECOM (+11%) logged strong performances within financials and industrials, respectively.

Letter to Shareholders

PRIMECAP Odyssey Funds

continued

The top 10 holdings, which collectively represented 32.8% of the portfolio at the period end, are listed below:



PRIMECAP Odyssey Stock Fund Top 10 Holdings as of 10/31/22	Ending % of Total Portfolio*
Eli Lilly & Co.		7.8
AstraZeneca PLC – ADR		4.0
AECOM		3.9
Amgen, Inc.		2.9
Biogen, Inc.		2.7
Wells Fargo & Co.		2.6
Microsoft Corp.		2.4
Bristol-Myers Squibb Co.		2.3
Flex Ltd.		2.1
FedEx Corp.		2.1
Total % of Portfolio		32.8

The percentage is calculated by using the ending market value of the security divided by the ending market value of the total investments of the Fund.

PRIMECAP Odyssey Growth Fund

For the fiscal year ended October 31, 2022, the Growth Fund returned -17.61%, trailing the S&P 500^®’s -14.61% total return but exceeding the Russell 1000 Growth Index’s total return of -24.60%. Unfavorable stock selection more than offset favorable sector allocation relative to the S&P 500^®.

Sector allocation was slightly less advantageous than that of the Stock Fund given more exposure to communication services (5%) and less to industrials (13%). These incremental headwinds were partially offset by the Growth Fund’s larger health care overweight (30%) and less pronounced energy underweight (3%).

Stock selection was unfavorable overall. Despite several familiar health care outperformers –Eli Lilly, Amgen, and Biogen, plus BioMarin (+9%) – the Growth Fund’s greater biotechnology exposure detracted from results, especially Nektar (-75%) and BeiGene (-53%). Selection within consumer discretionary and information technology was also notably more unfavorable, with large positions in Alibaba (-61%) and Splunk (-50%), respectively, weighing heavily on sector-level performance.

Letter to Shareholders

PRIMECAP Odyssey Funds

continued

The top 10 holdings, which collectively represented 30.1% of the portfolio at the period end, are listed below:



PRIMECAP Odyssey Growth Fund Top 10 Holdings as of 10/31/22	Ending % of Total Portfolio*
Eli Lilly & Co.		6.5
AECOM		3.5
Biogen, Inc.		3.2
Raymond James Financial, Inc.		3.1
Amgen, Inc.		2.7
Alphabet Inc. – Class A & C		2.6
ABIOMED, Inc.		2.3
BioMarin Pharmaceutical, Inc.		2.1
Insulet Corp.		2.1
Micron Technology, Inc.		2.0
Total % of Portfolio		30.1

The percentage is calculated by using the ending market value of the security divided by the ending market value of the total investments of the Fund.

PRIMECAP Odyssey Aggressive Growth Fund

For the fiscal year ended October 31, 2022, the Aggressive Growth Fund’s total return of -28.21% trailed the S&P 500^®’s total return of -14.61% but slightly exceeded the Russell Midcap Growth Index’s total return of -28.94%. Unfavorable stock selection was the primary driver of underperformance relative to the S&P 500^®, while sector allocation provided a modest offset.

The Aggressive Growth Fund’s sector allocation benefit was quite limited. The main culprit relative to its Odyssey Fund peers was a reduced position (less than 1% of average assets) in the high-performing energy sector. Likewise, even more so than the Growth Fund, the Fund suffered from greater exposure to communication services (6%) and less exposure to industrials (12%).

Stock selection was more unfavorable than the Growth Fund, albeit for similar reasons. As its name implies, the Fund’s more ‘aggressive’ growth orientation amid an unforgiving landscape for growth stocks proved especially punitive relative to the benchmark. Health care selection was a significant headwind, as the familiar winners (such as Eli Lilly and Biogen) were less consequential while several key holdings struggled. BioNTech (-50%) retrenched after a two-year Covid-fueled explosion; Pulmonx (-66%) plus larger positions in Nektar and BeiGene also detracted from results. Rhythm Pharmaceuticals (+119%) was a notable offset, as its drug for severe obesity, Imcivree, cleared several milestones. Within information technology and consumer discretionary, growth stocks again

Letter to Shareholders

PRIMECAP Odyssey Funds

continued

dragged on relative results. The collapses in HubSpot (-63%) and MaxLinear (-51%), for instance, were representative of widespread weakness in high-multiple software and semiconductor stocks, respectively. And positions in Tesla and its Chinese EV competitor, Xpeng (-86%), contributed to underperformance in the consumer discretionary sector.

The top 10 holdings, which collectively represented 30.4% of the portfolio at the period end, are listed below:



PRIMECAP Odyssey Aggressive Growth Fund Top 10 Holdings as of 10/31/22	Ending % of Total Portfolio*
Eli Lilly & Co.		4.4
Biogen, Inc.		3.6
Micron Technology, Inc.		3.0
Seagen, Inc.		3.0
Tesla, Inc.		2.9
BioNTech SE – ADR		2.8
Sony Group Corp. – ADR		2.8
ABIOMED, Inc.		2.7
AECOM		2.7
BioMarin Pharmaceutical, Inc.		2.5
Total % of Portfolio		30.4

The percentage is calculated by using the ending market value of the security divided by the ending market value of the total investments of the Fund.

Outlook

Following late October’s market rebound, the S&P 500^® Index’s valuation returned to modestly elevated levels (16.7x forward P/E versus 15.5x 20-year average). But interest rates soared during the period, undermining a key rationale for above-average equity multiples; the 4.1% 10-year Treasury yield is now comparable to its longer-term historical norm. Meanwhile, recent earnings reports have generally disappointed, and the stronger dollar has a direct negative impact on near-term earnings given companies’ substantial foreign exposures. Forward earnings expectations are thus likely too high. Additionally, we remain wary of above-average macroeconomic risks, most obviously a Fed intent on reducing aggregate demand. These concerns leave us somewhat cautious overall, even after the market’s recalibration.

More broadly, we assess this year’s developments as a potential paradigm shift in the market. Notwithstanding an occasional glitch, the decade-plus since the Great Recession had been remarkably benign: accommodative financial conditions, steady if modest global economic

Letter to Shareholders

PRIMECAP Odyssey Funds

continued

growth, and a relentless equity bull market. A pliant Fed, offering investors quasi-insurance in the form of a “Fed put,” underwrote a “buy the dip” mentality that became ubiquitous.

But the COVID-19 era, both the virus and especially the policy response, ultimately sowed enough dislocation to tip the proverbial apple cart. Ironically, it was Covid’s abrupt fade – its welcome shift to endemic status – that applied the final push. The mass normalization of society, coupled with two years of excessive money supply growth, unleashed the worst inflation in forty years.

The hallmarks of the prior paradigm – low interest rates, inflation, and growth – bred a certain type of winner. Big Tech stocks were perhaps the ultimate winners, highlighted by the ascendance of FAANG stocks (Apple, Amazon, Alphabet, Meta, and Netflix) – plus a few select peers. A new paradigm would presumably upend this dynamic, as investors migrate from yesterday’s darlings to fresh leadership. And, as previously mentioned, these stocks indeed struggled this year; Meta, Netflix, Amazon, and Alphabet all badly lagged the market’s decline.

That said, picking the next winners is never straightforward. Despite largely avoiding Big Tech weakness, the Growth and Aggressive Growth Funds still struggled in relative terms due to their own idiosyncratic miscues. The Funds’ unconventional ownership of small-capitalization biotechnology and Chinese technology stocks, for instance, discussed at length in recent letters, has fared poorly of late. The Funds continue to own numerous beaten-down stocks in these industries.

The Funds also own underappreciated successes, however, including Eli Lilly, the Funds’ largest position. Lilly has long been a meaningful Fund position – it was the Stock and Growth Funds’ largest holding at the start of the year, and a Top 10 Aggressive Growth Fund position, as well. Its outsized gains during the period (+44%) catapulted the stock to the top of all three Funds, and it finished the period between 4 and 8 percent of each Fund’s year-end assets, multiples above its benchmark weighting of less than 1 percent.

Like several Fund stock narratives, the Lilly story began nearly two decades ago. The Stock and Growth Funds initiated positions in the 2000s as Lilly was approaching patent cliffs for its so-called “twin towers” of Zyprexa and Cymbalta. The market, foreseeing a collapse in revenue and earnings, assigned Lilly an anemic valuation. But this ignored a key plotline: the company’s earnings were disproportionately depressed by healthy R&D spend, and its promising pipeline had huge potential. Looking through our long-term lens, we identified this latent opportunity, which had been obscured by the market’s obsession with near-term dynamics. It took time, but by the mid-2010s Lilly had returned to robust revenue growth on the back of a stable of new products. Its earnings climbed and its multiple expanded.

But the story was not over. The Funds stayed invested (and the Aggressive Growth Fund joined the bloc) because of our optimism regarding two pipeline drugs that were largely overlooked by Wall Street’s sell-side consensus, each with transformative blockbuster potential: tirzepatide

Letter to Shareholders

PRIMECAP Odyssey Funds

continued

(brand name Mounjaro) for obesity and donanemab for Alzheimer’s. Since then, tirzepatide surpassed trial expectations, achieving approval in diabetes with additional approval in obesity expected next year. And donanemab, despite skepticism regarding the beta amyloid hypothesis, continues to make regulatory progress. Following in Biogen’s choppy wake, donanemab faces ample investor doubt – but there persists an enormous unmet need for a desperate Alzheimer’s population, and the commercial opportunity is staggering. The stock’s spectacular run has generated a superficially-high valuation (40.0x forward P/E), but earnings could plausibly quadruple in the mid-term as these drugs are absorbed by Lilly’s income statement. We believe that combined with a best-in-class management team, these two drugs (and the rest of Lilly’s pipeline) can deliver another decade-long chapter in this remarkable success story.

Meanwhile, in stark juxtaposition, the Funds have no exposure to Apple. Unlike its Big Tech peers, Apple has thus far avoided a major stumble. Its market capitalization is north of two trillion dollars, and it now represents roughly 7 percent of the S&P 500^® – a record-high weighting for any constituent since 1980. The company’s multiple re-rated higher pre-Covid and valuation has sustained at elevated levels (24.3x forward P/E). Apple is a premier brand that has made a habit of revolutionizing the consumer electronics industry. But it undeniably benefited from COVID-19, and its mid-term earnings outlook is uninspiring – in contrast to Lilly’s imminent inflection.

Each of these two Fund “positions” – a massive Lilly overweight and corresponding Apple underweight – is a material departure from the benchmark. Each position embodies a high-conviction, inherently contrarian belief. Such deviation is emblematic of the Funds’ differentiated investment philosophy and process. And on the eve – or in the midst – of a paradigm change, we prefer the Funds’ distinctive portfolios to the benchmark status quo.

Tomorrow’s longer-term winners are, as always, uncertain. The contours of this potential new paradigm have yet to take shape. Rapidly rising rates tend to break things, and we expect wreckage if the Fed perseveres. But eventually we believe a less Fed-centric market will arise, one where fundamentals and valuations feature more prominently than last decade’s artificial backstop. We are optimistic our holdings’ long-term fundamentals and attractive valuations will benefit from this evolution.

Sincerely,

PRIMECAP Management Company

November 6, 2022

Past performance is not a guarantee of future results.

The funds invest in smaller companies, which involve additional risks such as limited liquidity and greater volatility. All funds may invest in foreign securities, which involves greater volatility and political, economic and currency risks and differences in accounting methods. Mutual fund investing involves risk, and loss of principal is possible. Growth stocks typically are more volatile than value stocks; however, value stocks have a lower expected growth rate in earnings and sales.

Letter to Shareholders

PRIMECAP Odyssey Funds

continued

Please refer to the Schedule of Investments for details of fund holdings. Fund holdings and sector allocations are subject to change at any time and are not recommendations to buy or sell any security.

The S&P 500^® is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market. The Russell 1000 Growth Index is an index that measures the performance of those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values (the Russell 1000 Index measures the performance of the large-cap segment of the U.S. equity universe). The Russell Midcap Growth Index measures the performance of those Russell Midcap companies with higher price-to-book ratios and higher forecasted growth values. You cannot invest directly in an index.

Earnings per share (EPS) is calculated by taking the total earnings divided by the number of shares outstanding.

Price-to-earnings (P/E) ratio is calculated by dividing the current share price of a stock by its earnings per share.

Earnings growth is not a prediction of a fund’s future performance.

The information provided herein represents the opinions of PRIMECAP Management Company and is not intended to be a forecast of future events, a guarantee of future results, or investment advice.

Performance Graphs

PRIMECAP Odyssey Stock Fund

The chart below illustrates the performance of a hypothetical $10,000 investment made on October 31, 2012 and is not intended to imply any future performance. The returns shown do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. The chart assumes reinvestment of dividends and capital gains for the fund and dividends for the index.

LOGO


	Total Return Period Ended October 31, 2022
	1 Year		Annualized 5 Year		Annualized 10 Year		Annualized Since Inception^
Stock Fund		-11.33%		8.15%		12.47%		9.83%
S&P 500^®*		-14.61%		10.44%		12.79%		9.25%

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the fund may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling 1-800-729-2307.

The S&P 500^® is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market.

November 1, 2004

Performance Graphs

PRIMECAP Odyssey Growth Fund

LOGO


	Total Return Period Ended October 31, 2022
	1 Year		Annualized 5 Year		Annualized 10 Year		Annualized Since Inception^
Growth Fund		-17.61%		7.66%		13.05%		10.39%
S&P 500^®*		-14.61%		10.44%		12.79%		9.25%

The S&P 500^® is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market.

November 1, 2004

Performance Graphs

PRIMECAP Odyssey Aggressive Growth Fund

LOGO


	Total Return Period Ended October 31, 2022
	1 Year		Annualized 5 Year		Annualized 10 Year		Annualized Since Inception^
Aggressive Growth Fund		-28.21%		5.27%		13.29%		11.47%
S&P 500^®*		-14.61%		10.44%		12.79%		9.25%

The S&P 500^® is a market capitalization-weighted index of 500 large-capitalization stocks commonly used to represent the U.S. equity market.

November 1, 2004

Sector Breakdown

PRIMECAP Odyssey Funds

PRIMECAP Odyssey Stock Fund


Communication Services			2.8%
Consumer Discretionary			9.0%
Consumer Staples			1.2%
Energy			2.9%
Financials			12.1%
Health Care			27.8%
Industrials			18.3%
Information Technology			20.0%
Materials			2.3%
Short-Term Investments, net of Liabilities in Excess of Other Assets			3.6%
Total			100.0%

PRIMECAP Odyssey Growth Fund


Communication Services			4.5%
Consumer Discretionary			10.4%
Consumer Staples			0.2%
Energy			3.5%
Financials			8.6%
Health Care			34.4%
Industrials			13.5%
Information Technology			21.7%
Materials			0.7%
Rights (Health Care)			0.0%
Short-Term Investments, net of Liabilities in Excess of Other Assets			2.5%
Total			100.0%

The tables above list sector allocations as a percentage of each fund’s total net assets as of October 31, 2022. The management report may make reference to average allocations during the period. As a result, the sector allocations above may differ from those discussed in the management report.

Sector Breakdown

PRIMECAP Odyssey Funds

continued

PRIMECAP Odyssey Aggressive Growth Fund


Communication Services			5.5%
Consumer Discretionary			11.8%
Consumer Staples			0.0%
Energy			1.2%
Financials			5.0%
Health Care			35.4%
Industrials			12.7%
Information Technology			25.1%
Materials			0.8%
Real Estate			0.1%
Preferred Stocks (Financials)			0.0%
Warrants (Materials)			0.0%
Rights (Health Care)			0.0%
Short-Term Investments, net of Liabilities in Excess of Other Assets			2.4%
Total			100.0%

The table above lists sector allocations as a percentage of the fund’s total net assets as of October 31, 2022. The management report may make reference to average allocations during the period. As a result, the sector allocations above may differ from those discussed in the management report.

Schedule of Investments

PRIMECAP Odyssey Stock Fund

October 31, 2022


Shares			Value
	COMMON STOCKS – 96.4%

Communication Services – 2.8%
	354,030	Activision Blizzard, Inc.	$	25,773,384
	372,480	Alphabet, Inc. – Class A (a)		35,203,085
	490,600	Alphabet, Inc. – Class C (a)		46,440,196
	138,600	Comcast Corp. – Class A		4,399,164
	75,200	Meta Platforms, Inc. – Class A (a)		7,005,632
	300,000	Nintendo Co. Ltd. – JPY		12,246,545
	271,600	Walt Disney Co. (The) (a)		28,936,264

				160,004,270

Consumer Discretionary – 9.0%
	424,100	Bath & Body Works, Inc.		14,156,458
	369,100	Brinker International, Inc. (a)		12,324,249
	25,700	Burlington Stores, Inc. (a)		3,674,072
	212,600	Capri Holdings Ltd. (a)		9,711,568
	521,900	CarMax, Inc. (a)		32,884,919
	1,268,700	Carnival Corp. (a)		11,494,422
	196,300	Dollar Tree, Inc. (a)		31,113,550
	230,650	eBay, Inc.		9,189,096
	217,800	Leslie’s, Inc. (a)		3,057,912
	4,676,700	Mattel, Inc. (a)		88,670,232
	82,310	MGM Resorts International		2,927,767
	740,000	Newell Brands, Inc.		10,219,400
	898,340	Ross Stores, Inc.		85,962,154
	184,550	Royal Caribbean Cruises Ltd. (a)		9,851,279
	1,496,819	Sony Group Corp. – ADR		100,990,378
	230,400	TJX Cos., Inc. (The)		16,611,840
	227,599	Victoria’s Secret & Co. (a)		8,557,722
	526,529	Whirlpool Corp.		72,787,369

				524,184,387

Consumer Staples – 1.2%
	207,300	Altria Group, Inc.		9,591,771
	283,600	BJ’s Wholesale Club Holdings, Inc. (a)		21,950,640
	105,300	Philip Morris International, Inc.		9,671,805
	229,500	Sysco Corp.		19,865,520
	149,800	Tyson Foods, Inc. – Class A		10,238,830

				71,318,566

Energy – 2.9%
	172,400	Cameco Corp.		4,089,328
	250,600	EOG Resources, Inc.		34,211,912

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Stock Fund

October 31, 2022 – continued


Shares			Value
Energy (continued)
	348,400	Hess Corp.	$	49,152,272
	170,600	Pioneer Natural Resources Co.		43,743,546
	1,390,000	Southwestern Energy Co. (a)		9,632,700
	235,000	TechnipFMC PLC (a)		2,488,650
	922,800	Transocean Ltd. (a)		3,395,904
	177,600	Valero Energy Corp.		22,297,680

				169,011,992

Financials – 12.1%
	2,036,330	Bank of America Corp.		73,389,333
	265,000	Charles Schwab Corp. (The)		21,112,550
	1,193,150	Citigroup, Inc.		54,717,859
	236,000	CME Group, Inc. – Class A		40,898,800
	690,220	Discover Financial Services		72,100,381
	41,590	Evercore, Inc. – Class A		4,371,109
	863,220	JPMorgan Chase & Co.		108,662,134
	580,880	Northern Trust Corp.		48,997,228
	75,130	Progressive Corp. (The)		9,646,692
	974,765	Raymond James Financial, Inc.		115,158,737
	3,305,908	Wells Fargo & Co.		152,038,709

				701,093,532

Health Care – 27.8%
	255,960	Abbott Laboratories		25,324,682
	459,100	Agilent Technologies, Inc.		63,516,485
	46,500	Alcon, Inc.		2,821,620
	624,200	Amgen, Inc.		168,752,470
	3,978,680	AstraZeneca PLC – ADR		233,986,171
	555,850	Biogen, Inc. (a)		157,550,124
	349,800	Boston Scientific Corp. (a)		15,079,878
	1,699,300	Bristol-Myers Squibb Co.		131,644,771
	267,160	CVS Health Corp.		25,300,052
	1,873,690	Elanco Animal Health, Inc. (a)		24,713,971
	1,252,163	Eli Lilly & Co.		453,395,701
	27,000	IQVIA Holdings, Inc. (a)		5,661,090
	387,000	LivaNova PLC (a)		18,227,700
	38,010	Medtronic PLC		3,319,793
	85,300	Merck & Co., Inc.		8,632,360
	712,020	Novartis AG – ADR		57,766,183
	234,230	PerkinElmer, Inc.		31,288,443
	79,011	Roche Holding AG – CHF		26,239,684

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Stock Fund

October 31, 2022 – continued


Shares			Value
Health Care (continued)
	113,360	Sanofi – ADR	$	4,900,553
	262,398	Siemens Healthineers AG – EUR		12,078,881
	24,700	Stryker Corp.		5,662,228
	187,140	Thermo Fisher Scientific, Inc.		96,184,346
	6,980	Waters Corp. (a)		2,088,207
	312,790	Zimmer Biomet Holdings, Inc.		35,454,746
	4,200	ZimVie, Inc. (a)		36,834

				1,609,626,973

Industrials – 18.3%
	3,008,900	AECOM		226,509,992
	448,400	Airbus SE – EUR		48,558,314
	54,050	Alaska Air Group, Inc. (a)		2,403,063
	2,350,490	American Airlines Group, Inc. (a)		33,329,948
	34,900	AMETEK, Inc.		4,525,134
	391,872	Carrier Global Corp.		15,580,831
	142,223	Caterpillar, Inc.		30,785,590
	332,700	CSX Corp.		9,668,262
	274,940	Curtiss-Wright Corp.		46,143,180
	23,100	Deere & Co.		9,143,442
	916,450	Delta Air Lines, Inc. (a)		31,095,148
	747,285	FedEx Corp.		119,774,840
	85,070	General Dynamics Corp.		21,250,486
	111,200	GXO Logistics, Inc. (a)		4,063,248
	466,190	Jacobs Solutions, Inc.		53,714,412
	267,000	JELD-WEN Holding, Inc. (a)		2,832,870
	371,600	Kirby Corp. (a)		25,919,100
	2,500	Knight-Swift Transportation Holdings, Inc.		120,075
	23,300	L3Harris Technologies, Inc.		5,742,751
	226,900	Matson, Inc.		16,695,302
	594,120	Maxar Technologies, Inc.		13,272,641
	92,200	Norfolk Southern Corp.		21,028,054
	33,181	Otis Worldwide Corp.		2,343,906
	13,562	Raytheon Technologies Corp.		1,285,949
	18,310	Rockwell Automation, Inc.		4,674,543
	14,700	Saia, Inc. (a)		2,923,242
	1,055,708	Siemens AG – EUR		115,431,058
	2,544,380	Southwest Airlines Co. (a)		92,488,213
	30,400	Union Pacific Corp.		5,993,056
	1,401,900	United Airlines Holdings, Inc. (a)		60,393,852

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Stock Fund

October 31, 2022 – continued


Shares			Value
Industrials (continued)
	173,600	United Parcel Service, Inc. – Class B	$	29,124,872
	135,200	XPO Logistics, Inc. (a)		6,995,248

				1,063,810,622

Information Technology – 20.0%
	126,000	Adobe, Inc. (a)		40,131,000
	257,300	Analog Devices, Inc.		36,696,126
	627,650	Applied Materials, Inc.		55,415,218
	501,600	Cisco Systems, Inc.		22,787,688
	263,698	Corning, Inc.		8,483,165
	137,000	Fidelity National Information Services, Inc.		11,369,630
	6,152,179	Flex Ltd. (a)		120,459,665
	4,726,680	Hewlett Packard Enterprise Co.		67,449,724
	1,286,260	HP, Inc.		35,526,501
	3,598,610	Intel Corp.		102,308,482
	146,320	Keysight Technologies, Inc. (a)		25,481,628
	353,930	KLA Corp.		112,001,148
	5,845,580	L.M. Ericsson Telephone Co. – ADR		32,559,880
	602,450	Microsoft Corp.		139,846,718
	970,900	NetApp, Inc.		67,254,243
	19,310	NVIDIA Corp.		2,606,271
	901,580	Oracle Corp.		70,386,351
	175,510	PayPal Holdings, Inc. (a)		14,669,126
	379,607	QUALCOMM, Inc.		44,664,560
	20,000	Seagate Technology Holdings PLC		993,200
	165,500	Teradyne, Inc.		13,463,425
	514,540	Texas Instruments, Inc.		82,650,560
	131,500	Visa, Inc. – Class A		27,241,540
	145,140	WEX, Inc. (a)		23,823,280

				1,158,269,129

Materials – 2.3%
	198,200	Albemarle Corp.		55,470,234
	230,083	Corteva, Inc.		15,033,623
	199,383	Dow, Inc.		9,319,162
	215,784	DuPont de Nemours, Inc.		12,342,845
	504,900	Freeport-McMoRan, Inc.		16,000,281
	4,427,278	Glencore PLC – GBP		25,360,673

				133,526,818

	TOTAL COMMON STOCKS (Cost $3,090,099,522)		$	5,590,846,289

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Stock Fund

October 31, 2022 – continued


Shares			Value
	SHORT-TERM INVESTMENTS – 3.7%
	211,502,114	Dreyfus Treasury Securities Cash Management Fund – Institutional Shares – 3.01% (b)	$	211,502,114

	TOTAL SHORT-TERM INVESTMENTS (Cost $211,502,114)			211,502,114

	TOTAL INVESTMENTS IN SECURITIES (Cost $3,301,601,636) – 100.1%			5,802,348,403
	Liabilities in Excess of Other Assets – (0.1)%			(3,245,420	)

	TOTAL NET ASSETS – 100.0%		$	5,799,102,983

ADR	American Depository Receipt

CHF	Swiss Francs

EUR

Euros

GBP	British Pound Sterling

JPY	Japanese Yen

(a)	Non-Income Producing

(b)	Rate quoted is seven-day yield at period end.

The Global Industry Classification Standard (GICS ^®) was developed by and is the exclusive property of MSCI Inc. and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by the fund’s administrator.

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Growth Fund

October 31, 2022


Shares			Value
	COMMON STOCKS – 97.5%

Communication Services – 4.5%
	1,048,850	Alphabet, Inc. – Class A (a)	$	99,126,814
	872,750	Alphabet, Inc. – Class C (a)		82,614,515
	631,870	Baidu, Inc. – ADR (a)		48,382,286
	957,182	comScore, Inc. (a)		1,158,190
	96,000	Electronic Arts, Inc.		12,092,160
	220,100	IMAX Corp. (a)		2,801,873
	69,180	Live Nation Entertainment, Inc. (a)		5,507,420
	75,100	Meta Platforms, Inc. – Class A (a)		6,996,316
	10,000	Netflix, Inc. (a)		2,918,800
	550,000	Nintendo Co. Ltd. – JPY		22,451,999
	247,700	Walt Disney Co. (The) (a)		26,389,958

				310,440,331

Consumer Discretionary – 10.4%
	1,189,760	Alibaba Group Holding Ltd. – ADR (a)		75,644,941
	499,498	Bath & Body Works, Inc.		16,673,243
	137,410	Brinker International, Inc. (a)		4,588,120
	75,600	Burlington Stores, Inc. (a)		10,807,776
	510,300	Capri Holdings Ltd. (a)		23,310,504
	728,840	CarMax, Inc. (a)		45,924,208
	1,279,346	Carnival Corp. (a)		11,590,875
	121,200	Dollar Tree, Inc. (a)		19,210,200
	31,550	DoorDash, Inc. – Class A (a)		1,373,371
	145,460	eBay, Inc.		5,795,126
	1,801,124	Entain PLC – GBP		26,087,680
	76,143	Flutter Entertainment PLC – GBP (a)		10,111,767
	1,187,058	iRobot Corp. (a)		67,068,777
	78,400	Las Vegas Sands Corp. (a)		2,979,984
	247,900	Leslie’s, Inc. (a)		3,480,516
	39,300	Marriott International, Inc. – Class A		6,292,323
	3,196,850	Mattel, Inc. (a)		60,612,276
	93,230	MGM Resorts International		3,316,191
	633,800	Norwegian Cruise Line Holdings Ltd. (a)		10,704,882
	75,700	Ollie’s Bargain Outlet Holdings, Inc. (a)		4,239,200
	3,700	O’Reilly Automotive, Inc. (a)		3,097,529
	110,550	Ross Stores, Inc.		10,578,530
	621,571	Royal Caribbean Cruises Ltd. (a)		33,179,460
	1,182,947	Sony Group Corp. – ADR		79,813,434
	526,600	Tesla, Inc. (a)		119,822,564

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Growth Fund

October 31, 2022 – continued


Shares			Value
Consumer Discretionary (continued)
	202,200	TJX Cos., Inc. (The)	$	14,578,620
	265,099	Victoria’s Secret & Co. (a)		9,967,722
	727,310	Xometry, Inc. – Class A (a)		43,682,239

				724,532,058

Consumer Staples – 0.2%
	169,200	Altria Group, Inc.		7,828,884
	95,590	BJ’s Wholesale Club Holdings, Inc. (a)		7,398,666
	31,000	Grocery Outlet Holding Corp. (a)		1,071,670

				16,299,220

Energy – 3.5%
	718,100	Coterra Energy, Inc.		22,354,453
	106,900	EOG Resources, Inc.		14,593,988
	412,021	Hess Corp.		58,127,923
	447,400	Pioneer Natural Resources Co.		114,717,834
	1,900,000	Southwestern Energy Co. (a)		13,167,000
	6,291,104	Transocean Ltd. (a)		23,151,263

				246,112,461

Financials – 8.6%
	302,800	Bank of America Corp.		10,912,912
	407,000	Citigroup, Inc.		18,665,020
	96,600	CME Group, Inc. – Class A		16,740,780
	486,310	Discover Financial Services		50,799,943
	12,380	Evercore, Inc. – Class A		1,301,138
	174,100	JPMorgan Chase & Co.		21,915,708
	102,600	MarketAxess Holdings, Inc.		25,038,504
	746,140	Morgan Stanley		61,310,324
	560,980	Northern Trust Corp.		47,318,663
	1,826,375	Raymond James Financial, Inc.		215,767,942
	100,000	Tradeweb Markets, Inc. – Class A		5,508,000
	2,628,900	Wells Fargo & Co.		120,903,111

				596,182,045

Health Care – 34.4%
	229,918	Abbott Laboratories		22,748,087
	647,150	ABIOMED, Inc. (a)		163,133,572
	161,690	Agilent Technologies, Inc.		22,369,812
	62,860	Alcon, Inc.		3,814,345
	408,100	Alkermes PLC (a)		9,263,870
	704,660	Amgen, Inc.		190,504,831
	2,345,230	AstraZeneca PLC – ADR		137,922,976

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Growth Fund

October 31, 2022 – continued


Shares			Value
Health Care (continued)
	703,427	BeiGene Ltd. – ADR (a)	$	118,801,786
	782,840	Biogen, Inc. (a)		221,888,170
	1,702,716	BioMarin Pharmaceutical, Inc. (a)		147,506,287
	165,100	BioNTech SE – ADR		22,724,364
	831,700	Boston Scientific Corp. (a)		35,854,587
	205,492	Bridgebio Pharma, Inc. (a)		2,143,282
	1,186,500	Bristol-Myers Squibb Co.		91,918,155
	240,900	CVS Health Corp.		22,813,230
	55,000	Edwards Lifesciences Corp. (a)		3,983,650
	1,958,671	Elanco Animal Health, Inc. (a)		25,834,870
	1,258,078	Eli Lilly & Co.		455,537,463
	97,766	Enovis Corp. (a)		4,834,529
	1,868,340	FibroGen, Inc. (a)		30,416,575
	53,800	Guardant Health, Inc. (a)		2,663,100
	94,120	Illumina, Inc. (a)		21,536,538
	551,609	Insulet Corp. (a)		142,761,925
	22,860	IQVIA Holdings, Inc. (a)		4,793,056
	772,100	LivaNova PLC (a)		36,365,910
	28,800	Merck & Co., Inc.		2,914,560
	4,798,916	Nektar Therapeutics (a)		18,043,924
	1,000	Neurocrine Biosciences, Inc. (a)		115,120
	776,156	Novartis AG – ADR		62,969,536
	16,140	Omnicell, Inc. (a)		1,247,945
	149,600	OraSure Technologies, Inc. (a)		652,256
	73,120	PerkinElmer, Inc.		9,767,370
	179,910	QIAGEN N.V. – EUR (a)		7,769,685
	1,747,558	Rhythm Pharmaceuticals, Inc. (a)		43,986,035
	116,494	Roche Holding AG – CHF		38,687,851
	919,900	Seagen, Inc. (a)		116,974,484
	81,080	Siemens Healthineers AG – EUR		3,732,329
	165,000	Thermo Fisher Scientific, Inc.		84,805,050
	863,503	Xencor, Inc. (a)		24,178,084
	314,320	Zimmer Biomet Holdings, Inc.		35,628,172

				2,393,607,371

Industrials – 13.5%
	3,218,022	AECOM		242,252,696
	318,846	Airbus SE – EUR		34,528,600
	2,576,261	American Airlines Group, Inc. (a)		36,531,381
	60,000	AMETEK, Inc.		7,779,600

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Growth Fund

October 31, 2022 – continued


Shares			Value
Industrials (continued)
	95,000	Carrier Global Corp.	$	3,777,200
	238,900	Curtiss-Wright Corp.		40,094,587
	1,335,500	Delta Air Lines, Inc. (a)		45,313,515
	97,765	ESAB Corp.		3,646,634
	218,700	FedEx Corp.		35,053,236
	118,360	General Dynamics Corp.		29,566,328
	62,600	IDEX Corp.		13,916,606
	54,700	J.B. Hunt Transport Services, Inc.		9,357,529
	939,794	Jacobs Solutions, Inc.		108,283,065
	670,100	JetBlue Airways Corp. (a)		5,387,604
	360,501	Lyft, Inc. – Class A (a)		5,277,735
	22,200	Old Dominion Freight Line, Inc.		6,096,120
	17,200	Saia, Inc. (a)		3,420,392
	886,579	Siemens AG – EUR		96,938,502
	2,554,030	Southwest Airlines Co. (a)		92,838,990
	299,900	Textron, Inc.		20,525,156
	11,400	TransDigm Group, Inc.		6,563,664
	133,500	Uber Technologies, Inc. (a)		3,547,095
	55,500	Union Pacific Corp.		10,941,270
	1,855,750	United Airlines Holdings, Inc. (a)		79,945,710

				941,583,215

Information Technology – 21.7%
	180,900	Adobe, Inc. (a)		57,616,650
	583,500	Altair Engineering, Inc. – Class A (a)		28,620,675
	281,600	Analog Devices, Inc.		40,161,792
	328,100	Applied Materials, Inc.		28,967,949
	55,300	ASML Holding N.V. – ADR		26,124,826
	5,244,743	BlackBerry Ltd. (a)		24,440,502
	661,100	Cisco Systems, Inc.		30,033,773
	47,900	Dell Technologies, Inc. – Class C		1,839,360
	548,600	Descartes Systems Group, Inc. (The) (a)		37,891,802
	6,910,699	Flex Ltd. (a)		135,311,486
	586,956	FormFactor, Inc. (a)		11,862,381
	2,207,120	Hewlett Packard Enterprise Co.		31,495,602
	602,476	HP, Inc.		16,640,387
	1,420,440	Intel Corp.		40,383,109
	14,400	Intuit, Inc.		6,156,000
	585,000	Jabil, Inc.		37,586,250
	88,070	Keysight Technologies, Inc. (a)		15,337,391

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Growth Fund

October 31, 2022 – continued


Shares			Value
Information Technology (continued)
	317,124	KLA Corp.	$	100,353,890
	2,533,300	L.M. Ericsson Telephone Co. – ADR		14,110,481
	464,050	MaxLinear, Inc. (a)		14,329,864
	2,568,600	Micron Technology, Inc.		138,961,260
	501,900	Microsoft Corp.		116,506,047
	821,811	NetApp, Inc.		56,926,848
	572,800	Nutanix, Inc. – Class A (a)		15,694,720
	88,580	NVIDIA Corp.		11,955,643
	364,100	Oracle Corp.		28,425,287
	55,000	OSI Systems, Inc. (a)		4,519,900
	39,100	Palo Alto Networks, Inc. (a)		6,709,169
	25,600	PayPal Holdings, Inc. (a)		2,139,648
	324,600	QUALCOMM, Inc.		38,192,436
	39,400	Salesforce, Inc. (a)		6,406,046
	1,544,230	Splunk, Inc. (a)		128,340,955
	1,827,599	Stratasys Ltd. (a)		26,445,358
	142,900	Teradyne, Inc.		11,624,915
	505,115	Texas Instruments, Inc.		81,136,622
	392,050	Trimble, Inc. (a)		23,585,728
	284,066	Universal Display Corp.		27,048,765
	198,850	Visa, Inc. – Class A		41,193,766
	23,000	VMware, Inc. – Class A		2,588,190
	26,000	Western Digital Corp. (a)		893,620
	84,810	WEX, Inc. (a)		13,920,713
	326,700	Wolfspeed, Inc. (a)		25,727,625

				1,508,207,431

Materials – 0.7%
	160,600	Albemarle Corp.		44,947,122


	TOTAL COMMON STOCKS (Cost $3,732,013,290)		$	6,781,911,254

	RIGHTS – 0.0%

Health Care – 0.0%
	4,207,543	Epizyme, Inc. – CVR (Issue Date 8/15/22) (a) (b) (c)		84,151

	TOTAL RIGHTS (Cost $0)			84,151

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Growth Fund

October 31, 2022 – continued


Shares			Value
	SHORT-TERM INVESTMENTS – 2.7%
	191,463,748	Dreyfus Treasury Securities Cash Management Fund – Institutional Shares – 3.01% (d)	$	191,463,748

	TOTAL SHORT-TERM INVESTMENTS (Cost $191,463,748)			191,463,748

	TOTAL INVESTMENTS IN SECURITIES (Cost $3,923,477,038) – 100.2%			6,973,459,153
	Liabilities in Excess of Other Assets – (0.2)%			(15,874,834	)

	TOTAL NET ASSETS – 100.0%		$	6,957,584,319

ADR	American Depository Receipt

CHF	Swiss Francs

CVR	Contingent Value Rights

EUR

Euros

GBP	British Pound Sterling

JPY	Japanese Yen

(a)	Non-Income Producing

(b)	Illiquid security

(c)	Fair-valued security (Note 4)

(d)	Rate quoted is seven-day yield at period end.

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022


Shares			Value
	COMMON STOCKS – 97.6%

Communication Services – 5.5%
	769,550	Alphabet, Inc. – Class A (a)	$	72,730,170
	712,640	Alphabet, Inc. – Class C (a)		67,458,502
	987,700	Baidu, Inc. – ADR (a)		75,628,189
	3,571,140	comScore, Inc. (a)		4,321,079
	100,800	Electronic Arts, Inc.		12,696,768
	682,300	IMAX Corp. (a)		8,685,679
	142,665	Live Nation Entertainment, Inc. (a)		11,357,561
	586,128	Madison Square Garden Entertainment Corp. – Class A (a)		28,737,856
	2,850	Madison Square Garden Sports Corp. – Class A		446,339
	80,700	Meta Platforms, Inc. – Class A (a)		7,518,012
	10,400	Netflix, Inc. (a)		3,035,552
	1,615,150	Pinterest, Inc. – Class A (a)		39,732,690
	25,900	Roblox Corp. – Class A (a)		1,158,766
	105,300	Snap, Inc. – Class A (a)		1,043,523
	218,120	T-Mobile US, Inc. (a)		33,058,267
	6,709,170	WildBrain Ltd. – CAD (a)		10,194,137
	94,319	ZoomInfo Technologies, Inc. (a)		4,200,025

				382,003,115

Consumer Discretionary – 11.8%
	1,147,900	Alibaba Group Holding Ltd. – ADR (a)		72,983,482
	146,500	Amazon.com, Inc. (a)		15,007,460
	69,300	Boot Barn Holdings, Inc. (a)		3,936,240
	104,900	Burlington Stores, Inc. (a)		14,996,504
	143,537	Capri Holdings Ltd. (a)		6,556,770
	785,000	CarMax, Inc. (a)		49,462,850
	13,500	Darden Restaurants, Inc.		1,932,390
	350	Dollar General Corp.		89,267
	1,300	Duolingo, Inc. (a)		106,392
	264,850	eBay, Inc.		10,551,624
	3,659,109	Entain PLC – GBP		52,998,941
	8,000	Five Below, Inc. (a)		1,170,800
	22,700	Flutter Entertainment PLC – GBP (a)		3,014,553
	1,712,185	GAN Ltd. (a)		3,441,492
	104,000	Gildan Activewear, Inc.		3,281,200
	846,100	GrowGeneration Corp. (a)		3,020,577
	949,175	iRobot Corp. (a)		53,628,388
	1,059,865	Norwegian Cruise Line Holdings Ltd. (a)		17,901,120

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022 – continued


Shares			Value
Consumer Discretionary (continued)
	199,610	Ollie’s Bargain Outlet Holdings, Inc. (a)	$	11,178,160
	61,200	Restaurant Brands International, Inc.		3,634,056
	63,860	Rivian Automotive, Inc. – Class A (a)		2,233,184
	969,676	Royal Caribbean Cruises Ltd. (a)		51,761,305
	2,892,440	Sony Group Corp. – ADR		195,152,927
	879,850	Tesla, Inc. (a)		200,201,069
	945,200	Tuesday Morning Corp. (a)		125,239
	27,400	Ulta Beauty, Inc. (a)		11,490,738
	127,400	Victoria’s Secret & Co. (a)		4,790,240
	3,015,250	XPeng, Inc. – ADR (a)		19,960,955

				814,607,923

Consumer Staples – 0.0%
	18,300	Calavo Growers, Inc.		632,997
	65,000	Grocery Outlet Holding Corp. (a)		2,247,050

				2,880,047

Energy – 1.2%
	579,750	Coterra Energy, Inc.		18,047,617
	149,700	EOG Resources, Inc.		20,437,044
	167,500	New Fortress Energy, Inc.		9,224,225
	8,883,882	Transocean Ltd. (a)		32,692,686

				80,401,572

Financials – 5.0%
	192,700	AssetMark Financial Holdings, Inc. (a)		3,990,817
	7,600	Charles Schwab Corp. (The)		605,492
	144,471	CME Group, Inc. – Class A		25,036,824
	340,743	Discover Financial Services		35,594,014
	116,700	Galaxy Digital Holdings Ltd. – CAD (a)		567,931
	76,000	LPL Financial Holdings, Inc.		19,429,400
	530,220	MarketAxess Holdings, Inc.		129,394,889
	915,752	Morgan Stanley		75,247,342
	711,400	NMI Holdings, Inc. – Class A (a)		15,601,002
	121,280	Progressive Corp. (The)		15,572,352
	465,900	Tradeweb Markets, Inc. – Class A		25,661,772

				346,701,835

Health Care – 35.4%
	284,100	Abbott Laboratories		28,108,854
	749,973	ABIOMED, Inc. (a)		189,053,194
	229,300	Accuray, Inc. (a)		467,772
	108,200	Adaptive Biotechnologies Corp. (a)		841,796

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022 – continued


Shares			Value
Health Care (continued)
	1,474,410	Alkermes PLC (a)	$	33,469,107
	1,983,820	Allogene Therapeutics, Inc. (a)		20,433,346
	1,298,200	Amicus Therapeutics, Inc. (a)		12,982,000
	413,800	Arbutus Biopharma Corp. (a)		968,292
	748,627	BeiGene Ltd. – ADR (a)		126,435,614
	6,145	Berkeley Lights, Inc. (a)		13,642
	879,739	Biogen, Inc. (a)		249,353,222
	1,976,810	BioMarin Pharmaceutical, Inc. (a)		171,251,050
	1,419,292	BioNTech SE – ADR		195,351,351
	423,000	Boston Scientific Corp. (a)		18,235,530
	478,338	Bridgebio Pharma, Inc. (a)		4,989,065
	279,715	Calithera Biosciences, Inc. (a) (b)		702,085
	9,212,700	Cerus Corp. (a) (b)		33,718,482
	15,250	Charles River Laboratories International, Inc. (a)		3,236,812
	90,300	Edwards Lifesciences Corp. (a)		6,540,429
	673,092	Elanco Animal Health, Inc. (a)		8,878,083
	848,294	Eli Lilly & Co.		307,158,774
	437,600	Exact Sciences Corp. (a)		15,219,728
	4,243,131	FibroGen, Inc. (a)		69,078,173
	465,320	Glaukos Corp. (a)		26,090,492
	108,269	Guardant Health, Inc. (a)		5,359,316
	462,706	Health Catalyst, Inc. (a)		4,081,067
	11,980	Illumina, Inc. (a)		2,741,264
	219,500	ImmunoGen, Inc. (a)		1,303,830
	566,846	Insulet Corp. (a)		146,705,413
	887,000	LivaNova PLC (a)		41,777,700
	218,030	Mereo Biopharma Group PLC – ADR (a)		218,008
	10,301,870	Nektar Therapeutics (a) (b)		38,735,031
	76,400	NuVasive, Inc. (a)		3,371,532
	688,800	OraSure Technologies, Inc. (a)		3,003,168
	19,500	Penumbra, Inc. (a)		3,343,665
	3,685,191	Pulmonx Corp. (a) (b)		49,234,152
	206,220	QIAGEN N.V. – EUR (a)		8,905,923
	20,886	Repligen Corp. (a)		3,811,486
	5,016,580	Rhythm Pharmaceuticals, Inc. (a) (b)		126,267,319
	118,800	Roche Holding AG – CHF		39,453,678
	72,700	Sage Therapeutics, Inc. (a)		2,737,882
	1,621,093	Seagen, Inc. (a)		206,138,186
	253,930	Shockwave Medical, Inc. (a)		74,439,580

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022 – continued


Shares			Value
Health Care (continued)
	14,400	Sio Gene Therapies, Inc. (a)	$	4,219
	3,943,132	Standard BioTools, Inc. (a) (b)		4,652,896
	3,745,470	Wave Life Sciences Ltd. (a)		17,940,801
	4,398,717	Xencor, Inc. (a) (b)		123,164,076
	849,490	Zentalis Pharmaceuticals, Inc. (a)		21,313,704

				2,451,280,789

Industrials – 12.7%
	2,486,500	AECOM		187,183,720
	501,600	Alaska Air Group, Inc. (a)		22,301,136
	25,100	Allegiant Travel Co. (a)		1,883,755
	4,705,400	American Airlines Group, Inc. (a)		66,722,572
	2,320,300	Array Technologies, Inc. (a)		41,997,430
	3,503,800	Aurora Innovation, Inc. – Class A (a)		7,217,828
	181,000	Axon Enterprise, Inc. (a)		26,324,640
	49,600	Bloom Energy Corp. – Class A (a)		928,016
	41,000	Controladora Vuela Compania de Aviacion, S.A.B. de C.V. – ADR (a)		343,580
	232,310	Curtiss-Wright Corp.		38,988,587
	2,555,947	Delta Air Lines, Inc. (a)		86,723,282
	19,600	FedEx Corp.		3,141,488
	42,400	Frontier Group Holdings, Inc. (a)		555,864
	245,300	Gibraltar Industries, Inc. (a)		12,529,924
	181,900	Hawaiian Holdings, Inc. (a)		2,624,817
	567,700	Hertz Global Holdings, Inc. (a)		10,445,680
	970,430	Jacobs Solutions, Inc.		111,812,945
	3,076,900	JetBlue Airways Corp. (a)		24,738,276
	2,008,700	Li-Cycle Holdings Corp. (a)		11,971,852
	384,120	Lyft, Inc. – Class A (a)		5,623,517
	179,500	Masonite International Corp. (a)		12,839,635
	1,700,360	NN, Inc. (a)		4,233,896
	13,600	Old Dominion Freight Line, Inc.		3,734,560
	15,800	Ryanair Holdings PLC – ADR (a)		1,088,462
	1,789,140	Southwest Airlines Co. (a)		65,035,239
	242,400	Spirit Airlines, Inc.		5,332,800
	28,815	Sun Country Airlines Holdings, Inc. (a)		469,108
	38,150	TransDigm Group, Inc.		21,965,244
	20,000	TuSimple Holdings, Inc. – Class A (a)		68,600
	353,200	Uber Technologies, Inc. (a)		9,384,524
	2,165,360	United Airlines Holdings, Inc. (a)		93,283,709

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022 – continued


Shares			Value
Industrials (continued)
	42,400	WillScot Mobile Mini Holdings Corp. (a)	$	1,803,272

				883,297,958

Information Technology – 25.1%
	175,300	Adobe, Inc. (a)		55,833,050
	108,310	Ambarella, Inc. (a)		5,927,806
	109,200	Applied Materials, Inc.		9,641,268
	2,770,800	Arlo Technologies, Inc. (a)		14,269,620
	46,200	ASML Holding N.V. – ADR		21,825,804
	31,700	Autodesk, Inc. (a)		6,793,310
	1,513,245	Axcelis Technologies, Inc. (a)		87,768,210
	10,749,366	BlackBerry Ltd. (a)		50,092,046
	49,500	Cerence, Inc. (a)		851,400
	70,300	Credo Technology Group Holding Ltd. (a)		965,922
	132,899	CrowdStrike Holdings, Inc. – Class A (a)		21,423,319
	77,050	CyberArk Software Ltd. (a)		12,089,916
	91,300	Dell Technologies, Inc. – Class C		3,505,920
	721,341	Descartes Systems Group, Inc. (The) (a)		49,823,023
	200	DocuSign, Inc. (a)		9,660
	49,500	FARO Technologies, Inc. (a)		1,445,895
	7,558,250	Flex Ltd. (a)		147,990,535
	15,500	Flywire Corp. (a)		340,225
	911,155	FormFactor, Inc. (a)		18,414,443
	108,500	Freshworks, Inc. – Class A (a)		1,474,515
	27,920	GitLab, Inc. – Class A (a)		1,353,003
	997,100	Hewlett Packard Enterprise Co.		14,228,617
	375,670	HP, Inc.		10,376,005
	135,100	HubSpot, Inc. (a)		40,065,256
	2,425,800	indie Semiconductor, Inc. – Class A (a)		18,969,756
	116,250	Intuit, Inc.		49,696,875
	696,500	Jabil, Inc.		44,750,125
	88,800	Jamf Holding Corp. (a)		2,101,896
	55,210	Keysight Technologies, Inc. (a)		9,614,821
	128,904	Keywords Studios PLC – GBP		3,562,640
	351,430	KLA Corp.		111,210,023
	122,500	Marqeta, Inc. – Class A (a)		965,300
	160,730	Materialise NV – ADR (a)		1,702,131
	1,875,130	MaxLinear, Inc. (a)		57,904,014
	3,839,700	Micron Technology, Inc.		207,727,770
	350,400	Mobileye Global, Inc. – Class A (a)		9,243,552

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022 – continued


Shares			Value
Information Technology (continued)
	24,550	MongoDB, Inc. (a)	$	4,493,387
	1,063,567	NetApp, Inc.		73,673,286
	1,005,033	nLIGHT, Inc. (a)		10,824,205
	1,977,465	Nutanix, Inc. – Class A (a)		54,182,541
	208,300	NVIDIA Corp.		28,114,251
	89,000	Okta, Inc. – Class A (a)		4,994,680
	200,440	OSI Systems, Inc. (a)		16,472,159
	74,410	Palo Alto Networks, Inc. (a)		12,768,012
	320,050	PROS Holdings, Inc. (a)		7,985,248
	344,623	QUALCOMM, Inc.		40,548,342
	176,900	Rapid7, Inc. (a)		8,008,263
	3,250	RingCentral, Inc. – Class A (a)		115,440
	1,735,310	Splunk, Inc. (a)		144,221,614
	1,429,800	Stratasys Ltd. (a)		20,689,206
	45,800	Tenable Holdings, Inc. (a)		1,861,312
	610,070	Trimble, Inc. (a)		36,701,811
	150,540	Unity Software, Inc. (a)		4,440,930
	844,169	Universal Display Corp.		80,381,772
	130,700	VMware, Inc. – Class A		14,707,671
	380,980	Western Digital Corp. (a)		13,094,283
	115,480	WEX, Inc. (a)		18,954,887
	521,500	Wolfspeed, Inc. (a)		41,068,125
	70,300	Zoom Video Communications, Inc. – Class A (a)		5,865,832

				1,738,124,928

Materials – 0.8%
	91,100	Albemarle Corp.		25,496,157
	67,359	Bioceres Crop Solutions Corp. (a)		974,011
	34,500	Ingevity Corp. (a)		2,320,815
	2,699,400	Ivanhoe Mines Ltd. – Class A – CAD (a)		18,724,505
	1,358,552	Perimeter Solutions SA (a)		10,854,831

				58,370,319

Real Estate – 0.1%
	168,000	EPR Properties		6,484,800
	53,600	Safehold, Inc.		1,567,800

				8,052,600

	TOTAL COMMON STOCKS (Cost $4,370,456,336)		$	6,765,721,086

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022 – continued


Shares			Value
	PREFERRED STOCKS – 0.0%

Financials – 0.0%
	595,000	Freddie Mac Fixed-to-Floating Rate Non-Cumulative Preferred Stock Series Z, Perpetual Maturity 7.875% (a)	$	1,814,750

	TOTAL PREFERRED STOCKS (Cost $3,289,811)			1,814,750

	WARRANTS – 0.0%

Materials – 0.0%
	364,100	Perimeter Solutions SA (Expiration Date 11/8/24) (a)		709,995

	TOTAL WARRANTS (Cost $3,641)			709,995

	RIGHTS – 0.0%

Health Care – 0.0%
	10,344,756	Epizyme, Inc. – CVR (Issue Date 8/15/22) (a) (c) (d)		206,895
	3,786,300	Mereo BioPharma Group PLC – CVR (Issue Date 4/23/19) (a) (c) (d)		0

				206,895

	TOTAL RIGHTS (Cost $0)			206,895

	SHORT-TERM INVESTMENTS – 2.5%
	170,943,658	Dreyfus Treasury Securities Cash Management Fund – Institutional Shares – 3.01% (e)	$	170,943,658

	TOTAL SHORT-TERM INVESTMENTS (Cost $170,943,658)			170,943,658

	TOTAL INVESTMENTS IN SECURITIES (Cost $4,544,693,446) – 100.1%			6,939,396,384
	Liabilities in Excess of Other Assets – (0.1)%			(8,325,099	)

	TOTAL NET ASSETS – 100.0%		$	6,931,071,285

ADR	American Depository Receipt

CAD	Canadian Dollars

CHF	Swiss Francs

CVR	Contingent Value Rights

EUR

Euros

GBP	British Pound Sterling

(a)	Non-Income Producing

The accompanying notes are an integral part of these financial statements.

Schedule of Investments

PRIMECAP Odyssey Aggressive Growth Fund

October 31, 2022 – continued

(b)	Considered an affiliated company of the fund as the fund owns 5% or more of the outstanding voting securities of such company. (Note 7)

(c)	Illiquid security

(d)	Fair-valued security (Note 4)

(e)	Rate quoted is seven-day yield at period end.

The accompanying notes are an integral part of these financial statements.

Statements of Assets and Liabilities

PRIMECAP Odyssey Funds

October 31, 2022


	PRIMECAP Odyssey Stock Fund		PRIMECAP Odyssey Growth Fund		PRIMECAP Odyssey Aggressive Growth Fund
ASSETS
Investments, at cost (unaffiliated)	$	3,301,601,636	$	3,923,477,038	$	4,008,563,537

Investments, at cost (affiliated)		—		—		536,129,909

Investments, at value (unaffiliated)		5,802,348,403		6,973,459,153		6,562,922,343
Investments, at value (affiliated)		—		—		376,474,041
Receivable for investments sold		1,802,728		7,884,200		3,583,554
Receivable for dividends and interest		7,253,216		7,850,496		2,735,618
Receivable for fund shares sold		2,281,651		2,434,490		1,733,276
Prepaid expenses and other assets		59,715		68,696		85,892

Total assets		5,813,745,713		6,991,697,035		6,947,534,724


LIABILITIES
Payable for investments purchased		104,310		1,398,430		254,474
Payable for fund shares repurchased		5,762,106		21,907,520		5,230,691
Payable to the advisor (Note 6)		8,051,620		9,962,535		10,215,781
Payable to custodian		17,973		22,958		20,009
Other accrued expenses and liabilities		706,721		821,273		742,484

Total liabilities		14,642,730		34,112,716		16,463,439


NET ASSETS	$	5,799,102,983	$	6,957,584,319	$	6,931,071,285


Number of shares issued and outstanding (unlimited shares authorized, $0.01 par value)		166,752,590		189,577,840		178,104,760


NET ASSET VALUE, OFFERING AND REDEMPTION PRICE PER SHARE	$	34.78	$	36.70	$	38.92


COMPONENTS OF NET ASSETS
Paid-in capital	$	2,709,301,766	$	3,205,113,503	$	3,950,614,078
Total distributable earnings		3,089,801,217		3,752,470,816		2,980,457,207


Net assets	$	5,799,102,983	$	6,957,584,319	$	6,931,071,285

The accompanying notes are an integral part of these financial statements.

Statements of Operations

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022


	PRIMECAP Odyssey Stock Fund			PRIMECAP Odyssey Growth Fund			PRIMECAP Odyssey Aggressive Growth Fund
INVESTMENT INCOME
Dividends (unaffiliated)⁽¹⁾	$	103,027,075		$	84,589,306		$	38,211,044
Interest income		1,931,756			1,647,590			1,942,294

Total investment income		104,958,831			86,236,896			40,153,338


Expenses
Advisory fees (Note 6)		36,416,482			45,180,706			48,029,077
Shareholder servicing		5,295,567			6,640,019			6,739,093
Trustee fees		237,285			237,285			237,285
Custody		122,242			151,820			138,963
Other		1,343,036			1,460,522			1,450,083

Total expenses		43,414,612			53,670,352			56,594,501


Net investment income (loss)		61,544,219			32,566,544			(16,441,163	)


REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY
Net realized gain (loss) on:
Investments (unaffiliated)		647,224,948			832,338,376			928,886,023
Investments (affiliated)		—			—			(172,600,404	)
Foreign currency transactions		(27,449	)		(84,221	)		4,606
Change in unrealized appreciation/depreciation on:
Investments (unaffiliated)		(1,508,520,339	)		(2,524,938,381	)		(3,739,369,414	)
Investments (affiliated)		—			—			(96,914,927	)
Foreign currency translations		(542,347	)		(512,055	)		(127,296	)


Net realized and unrealized loss on investments and foreign currency		(861,865,187	)		(1,693,196,281	)		(3,080,121,412	)


NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	(800,320,968	)	$	(1,660,629,737	)	$	(3,096,562,575	)

⁽¹⁾

Net of foreign taxes withheld of $1,941,249, $1,756,660, and $916,745, respectively.

The accompanying notes are an integral part of these financial statements.

Statements of Changes in Net Assets

PRIMECAP Odyssey Stock Fund


	Year Ended October 31, 2022			Year Ended October 31, 2021
INCREASE (DECREASE) IN NET ASSETS FROM:

OPERATIONS
Net investment income	$	61,544,219		$	50,107,278
Net realized gain (loss) on:
Investments		647,224,948			693,227,700
Foreign currency transactions		(27,449	)		109,255
Change in unrealized appreciation/depreciation on:
Investments		(1,508,520,339	)		1,906,515,848
Foreign currency translations		(542,347	)		(83,689	)

Net increase (decrease) in net assets resulting from operations		(800,320,968	)		2,649,876,392


NET DISTRIBUTIONS TO SHAREHOLDERS		(663,331,689	)		(521,946,602	)


CAPITAL SHARE TRANSACTIONS
Proceeds from shares sold		667,871,168			820,313,951
Proceeds from reinvestment of distributions		625,946,173			469,381,159
Cost of shares repurchased		(1,764,672,183	)		(1,928,638,760	)

Net decrease from capital share transactions		(470,854,842	)		(638,943,650	)


Total increase (decrease) in net assets		(1,934,507,499	)		1,488,986,140


NET ASSETS
Beginning of year		7,733,610,482			6,244,624,342

End of year	$	5,799,102,983		$	7,733,610,482


CHANGE IN CAPITAL SHARES
Shares outstanding, beginning of year		179,968,262			195,799,339

Shares sold		17,904,467			20,815,677
Shares issued on reinvestment of distributions		15,899,064			13,511,260
Shares repurchased		(47,019,203	)		(50,158,014	)

Decrease in capital shares		(13,215,672	)		(15,831,077	)

Shares outstanding, end of year		166,752,590			179,968,262

The accompanying notes are an integral part of these financial statements.

Statements of Changes in Net Assets

PRIMECAP Odyssey Growth Fund


	Year Ended October 31, 2022			Year Ended October 31, 2021
INCREASE (DECREASE) IN NET ASSETS FROM:

OPERATIONS
Net investment income	$	32,566,544		$	9,957,571
Net realized gain (loss) on:
Investments		832,338,376			1,333,530,262
Foreign currency transactions		(84,221	)		85,833
Change in unrealized appreciation/depreciation on:
Investments		(2,524,938,381	)		2,004,621,861
Foreign currency translations		(512,055	)		(96,195	)

Net increase (decrease) in net assets resulting from operations		(1,660,629,737	)		3,348,099,332


NET DISTRIBUTIONS TO SHAREHOLDERS		(1,188,273,747	)		(1,087,744,161	)


CAPITAL SHARE TRANSACTIONS
Proceeds from shares sold		764,196,219			922,066,332
Proceeds from reinvestment of distributions		1,137,615,421			1,047,279,976
Cost of shares repurchased		(2,263,851,289	)		(2,667,590,516	)

Net decrease from capital share transactions		(362,039,649	)		(698,244,208	)


Total increase (decrease) in net assets		(3,210,943,133	)		1,562,110,963


NET ASSETS
Beginning of year		10,168,527,452			8,606,416,489

End of year	$	6,957,584,319		$	10,168,527,452


CHANGE IN CAPITAL SHARES
Shares outstanding, beginning of year		200,231,866			213,490,110

Shares sold		19,065,925			19,494,793
Shares issued on reinvestment of distributions		26,388,667			25,066,538
Shares repurchased		(56,108,618	)		(57,819,575	)

Decrease in capital shares		(10,654,026	)		(13,258,244	)

Shares outstanding, end of year		189,577,840			200,231,866

The accompanying notes are an integral part of these financial statements.

Statements of Changes in Net Assets

PRIMECAP Odyssey Aggressive Growth Fund


	Year Ended October 31, 2022			Year Ended October 31, 2021
INCREASE (DECREASE) IN NET ASSETS FROM:

OPERATIONS
Net investment loss	$	(16,441,163	)	$	(44,974,829	)
Net realized gain on:
Investments		756,285,619			1,277,061,756
Foreign currency transactions		4,606			165,129
Change in unrealized appreciation/depreciation on:
Investments		(3,836,284,341	)		2,070,409,100
Unfunded commitment with a SPAC		—			(2,927,075	)
Foreign currency translations		(127,296	)		(117,845	)

Net increase (decrease) in net assets resulting from operations		(3,096,562,575	)		3,299,616,236


NET DISTRIBUTIONS TO SHAREHOLDERS		(1,124,701,183	)		(822,100,806	)


CAPITAL SHARE TRANSACTIONS
Proceeds from shares sold		787,713,914			1,003,449,519
Proceeds from reinvestment of distributions		1,074,932,684			780,448,114
Cost of shares repurchased		(2,445,463,848	)		(2,097,662,877	)
Other capital contribution		—			13,817

Net decrease from capital share transactions		(582,817,250	)		(313,751,427	)


Total increase (decrease) in net assets		(4,804,081,008	)		2,163,764,003


NET ASSETS
Beginning of year		11,735,152,293			9,571,388,290

End of year	$	6,931,071,285		$	11,735,152,293


CHANGE IN CAPITAL SHARES
Shares outstanding, beginning of year		194,391,937			199,125,574

Shares sold		17,617,406			17,501,649
Shares issued on reinvestment of distributions		20,852,234			14,689,406
Shares repurchased		(54,756,817	)		(36,924,692	)

Decrease in capital shares		(16,287,177	)		(4,733,637	)

Shares outstanding, end of year		178,104,760			194,391,937

The accompanying notes are an integral part of these financial statements.

Financial Highlights

PRIMECAP Odyssey Stock Fund

For a capital share outstanding throughout each year.


	Year Ended Oct. 31, 2022			Year Ended Oct. 31, 2021			Year Ended Oct. 31, 2020			Year Ended Oct. 31, 2019			Year Ended Oct. 31, 2018

Net asset value, beginning of year	$	42.97		$	31.89		$	34.33		$	31.79		$	31.02

Income (loss) from investment operations:
Net investment income		0.35	⁽¹⁾		0.27	⁽¹⁾		0.40	⁽¹⁾		0.46			0.33
Net realized and unrealized gain (loss) on investments and foreign currency		(4.78	)		13.57			(0.76	)		2.95			1.13

Total from investment operations		(4.43	)		13.84			(0.36	)		3.41			1.46

Less:
Dividends from net investment income		(0.28	)		(0.48	)		(0.47	)		(0.34	)		(0.30	)
Distributions from net realized gain		(3.48	)		(2.28	)		(1.61	)		(0.53	)		(0.39	)

Total distributions		(3.76	)		(2.76	)		(2.08	)		(0.87	)		(0.69	)

Net asset value, end of year	$	34.78		$	42.97		$	31.89		$	34.33		$	31.79


Total return		(11.33	%)		45.44	%		(1.48	%)		11.22	%		4.70	%

Ratios/supplemental data:
Net assets, end of year (millions)	$	5,799.1		$	7,733.6		$	6,244.6		$	10,274.3		$	10,157.1

Ratio of expenses to average net assets		0.66	%		0.65	%		0.65	%		0.65	%		0.64	%

Ratio of net investment income to average net assets		0.93	%		0.67	%		1.28	%		1.38	%		1.04	%

Portfolio turnover rate		4	%		6	%		8	%		6	%		5	%

⁽¹⁾

Calculated using the average shares method.

The accompanying notes are an integral part of these financial statements.

Financial Highlights

PRIMECAP Odyssey Growth Fund

For a capital share outstanding throughout each year.


	Year Ended Oct. 31, 2022			Year Ended Oct. 31, 2021			Year Ended Oct. 31, 2020			Year Ended Oct. 31, 2019			Year Ended Oct. 31, 2018

Net asset value, beginning of year	$	50.78		$	40.31		$	39.68		$	38.43		$	35.64

Income from investment operations:
Net investment income		0.16	⁽¹⁾		0.05	⁽¹⁾		0.16	⁽¹⁾		0.22			0.10
Net realized and unrealized gain (loss) on investments and foreign currency		(8.21	)		15.72			2.57			1.88			3.26

Total from investment operations		(8.05	)		15.77			2.73			2.10			3.36

Less:
Dividends from net investment income		(0.05	)		(0.17	)		(0.20	)		(0.12	)		(0.11	)
Distributions from net realized gain		(5.98	)		(5.13	)		(1.90	)		(0.73	)		(0.46	)

Total distributions		(6.03	)		(5.30	)		(2.10	)		(0.85	)		(0.57	)

Net asset value, end of year	$	36.70		$	50.78		$	40.31		$	39.68		$	38.43


Total return		(17.61	%)		41.97	%		6.83	%		5.75	%		9.48	%

Ratios/supplemental data:
Net assets, end of year (millions)	$	6,957.6		$	10,168.5		$	8,606.4		$	12,365.6		$	13,144.9

Ratio of expenses to average net assets		0.65	%		0.65	%		0.65	%		0.64	%		0.64	%

Ratio of net investment income to average net assets		0.40	%		0.10	%		0.42	%		0.53	%		0.26	%

Portfolio turnover rate		4	%		7	%		9	%		6	%		4	%

⁽¹⁾

Calculated using the average shares method.

The accompanying notes are an integral part of these financial statements.

Financial Highlights

PRIMECAP Odyssey Aggressive Growth Fund

For a capital share outstanding throughout each year.


	Year Ended Oct. 31, 2022			Year Ended Oct. 31, 2021			Year Ended Oct. 31, 2020			Year Ended Oct. 31, 2019			Year Ended Oct. 31, 2018

Net asset value, beginning of year	$	60.37		$	48.07		$	43.46		$	44.71		$	41.41

Income (loss) from investment operations:
Net investment income (loss)		(0.09	)⁽¹⁾		(0.22	)⁽¹⁾		(0.10	)⁽¹⁾		0.03			0.00	⁽²⁾
Net realized and unrealized gain (loss) on investments and foreign currency		(15.51	)		16.73			7.10			1.72			3.68

Total from investment operations		(15.60	)		16.51			7.00			1.75			3.68

Less:
Dividends from net investment income		—			—			—			(0.03	)		—
Distributions from net realized gain		(5.85	)		(4.21	)		(2.39	)		(2.97	)		(0.38	)

Total distributions		(5.85	)		(4.21	)		(2.39	)		(3.00	)		(0.38	)

Net asset value, end of year	$	38.92		$	60.37		$	48.07		$	43.46		$	44.71


Total return		(28.21	%)		35.53	%		16.52	%		4.71	%		8.90	%

Ratios/supplemental data:
Net assets, end of year (millions)	$	6,931.1		$	11,735.2		$	9,571.4		$	9,851.4		$	10,245.3

Ratio of expenses to average net assets		0.65	%		0.64	%		0.64	%		0.63	%		0.63	%

Ratio of net investment income (loss) to average net assets		(0.19	%)		(0.39	%)		(0.23	%)		0.01	%		(0.19	%)

Portfolio turnover rate		4	%		9	%		17	%		7	%		12	%

⁽¹⁾

Calculated using the average shares method.

⁽²⁾

Less than one cent per share.

The accompanying notes are an integral part of these financial statements.

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022

(1) Organization

PRIMECAP Odyssey Funds (the “Trust”) was organized on June 8, 2004 as a Delaware statutory trust and is registered as an open-end management investment company under the Investment Company Act of 1940, as amended (the “1940 Act”). The Trust is comprised of three series: PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund (the “Funds”), each of which is diversified within the meaning of the 1940 Act. PRIMECAP Management Company (the “Investment Advisor”) serves as investment advisor to the Funds. Each Fund commenced operations on November 1, 2004.

Each Fund’s investment objective is to achieve long-term capital appreciation. Each Fund is authorized to issue unlimited shares of beneficial interest. All shares of each Fund have equal rights with respect to voting. The PRIMECAP Odyssey Aggressive Growth Fund is closed to most new investors.

(2) Significant Accounting Policies

The Funds consistently follow the accounting policies set forth below which are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Funds are considered investment companies under U.S. GAAP and follow the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board Auditing Standards Codification Topic 946.

Security Valuation

Securities traded on a national securities exchange are valued at the last reported sales price at the close of regular trading on each day the exchanges are open for trading. Securities traded on the National Association of Securities Dealers Automated Quotations (“NASDAQ”) are valued at the NASDAQ Official Closing Price, which may not necessarily represent the last sale price. Non-U.S. traded stocks are valued at the last sale price or official closing price in the primary local market where the stock is traded. Securities traded on an exchange for which there have been no sales are valued at the mean between the bid and ask price. Because trading on most non-U.S. exchanges is normally completed before the close of the New York Stock Exchange, the value of securities traded on foreign exchanges can change by the time a Fund calculates its net asset value per share (“NAV”). To address these changes, the Funds may utilize adjustment factors provided by an independent pricing service to systematically value foreign securities at fair value. These adjustment factors are based on statistical analyses of subsequent movement in securities indices, specific security prices, and exchange rates in foreign markets.

Securities for which quotations are not readily available are valued at their respective fair values as determined in good faith by a valuation committee of the Investment Advisor in accordance with procedures approved by the Trust’s Board of Trustees. Pursuant to those procedures, the Board of Trustees has designated the Investment Advisor as the Funds’ valuation designee responsible for determining whether market quotations are readily available and reliable, and making good faith determinations of fair value when

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

appropriate. In determining fair value, the Funds take into account all relevant factors and available information. Consequently, the price of a security used by a Fund to calculate its NAV may differ from quoted or published prices for the same security. Fair value pricing involves subjective judgments, and there is no single standard for determining a security’s fair value. As a result, different mutual funds could reasonably arrive at a different fair value for the same security. It is possible that the fair value determined for a security is materially different from the value that could be realized upon the sale of that security or from the values that other mutual funds may determine.

Investments in other funds are valued at their respective net asset values as determined by those funds, in accordance with the 1940 Act.

Share Valuation

The NAV of a Fund is calculated by dividing the sum of the value of the securities held by the Fund, plus cash or other assets, minus all liabilities (including estimated accrued expenses), by the total number of outstanding shares of the Fund. The result is rounded to the nearest cent. The Funds’ shares will not be priced on the days on which the New York Stock Exchange is closed for trading.

Foreign Currency

Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates as of 4 p.m. Eastern time on the valuation date. Purchases and sales of investments and dividend and interest income are converted into U.S. dollars using the spot market rate of exchange prevailing on the respective dates of such translations. Realized foreign exchange gains or losses may arise from 1) sales of foreign currencies; 2) currency gains or losses realized between the trade and settlement dates on securities transactions; and 3) the difference between the recorded amounts of dividends, interest, and foreign withholding taxes and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized foreign exchange gains and losses arise from changes in foreign exchange rates on foreign denominated assets and liabilities other than investments in securities held at the end of the reporting period. Foreign securities and currency transactions may involve risks not associated with U.S. securities and currency.

Federal Income Taxes

Each Fund has elected to be treated as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986 (the “IRC”). Each Fund intends to distribute substantially all of its taxable income and any accumulated net realized capital gains. Accordingly, no provision for federal income taxes has been made in the financial statements.

The Funds may be subject to foreign taxes on income, gains on investments, or currency repatriation, a portion of which may be reclaimed. The Funds will accrue such taxes and reclaims as applicable based upon their current interpretations of the tax rules and regulations that exist in the markets in which they invest.

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

Each Fund has adopted accounting standards regarding recognition and measurement of tax positions taken or expected to be taken on a tax return. The Funds recognize interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the Statement of Operations. During the year ended October 31, 2022, the Funds did not incur any interest or penalties. As of October 31, 2022, open tax years include the tax years ended October 31, 2019 through October 31, 2022. No Fund is aware of any tax positions for which it is more likely than not that the total amounts of unrecognized tax benefits or loss will significantly change in the next 12 months.

Allocation of Expenses

Each Fund is charged for those expenses directly attributable to it. Expenses that are not directly attributable to a Fund are allocated among the Funds by an appropriate method based on the nature of the expense.

Security Transactions, Investment Income, and Distributions

Security transactions are accounted for on the trade date. Dividend income and distributions to shareholders are recorded on the ex-dividend date, and interest income is recognized on the accrual basis. Realized gains and losses are evaluated on the basis of identified costs. Premiums and discounts on the purchase of securities are amortized/accreted using the effective interest method. U.S. GAAP requires that permanent financial reporting and tax differences be reclassified in the capital accounts.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates, and such differences could be material.

Indemnification Obligations

Under the Trust’s organizational documents, its current and former officers and trustees are indemnified against certain liabilities arising out of the performance of their duties to the Funds. In addition, in the normal course of business, the Funds enter into contracts that contain a variety of representations and warranties that provide general indemnifications. The Funds’ maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Funds that have not yet occurred. Based on experience, the Funds would expect the risk of loss to be minimal.

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

(3) Investment Transactions

The cost of purchases and the proceeds from sales of securities, excluding short-term investments, for the year ended October 31, 2022 were as follows:


Fund	Purchases		Sales
Stock Fund	$	253,792,778	$	1,300,162,434
Growth Fund	$	320,021,277	$	1,783,446,713
Aggressive Growth Fund	$	346,619,243	$	1,957,715,110

(4) Valuation Measurements

The Funds have adopted fair valuation accounting standards which establish an authoritative definition of fair value and set forth a hierarchy for measuring fair value. These standards require additional disclosure about the various inputs and valuation techniques used to develop the measurements of fair value and a discussion of changes in valuation techniques and related inputs during the period. These standards define fair value as the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy is organized into three levels based upon the assumptions (referred to as “inputs”) used to value the asset or liability. These standards state that “observable inputs” reflect the significant assumptions that market participants would use in valuing an asset or liability based on market data obtained from independent sources. “Unobservable inputs” reflect the Funds’ own assumptions about the inputs market participants would use to value the asset or liability.

Various inputs are used in determining the value of each Fund’s investments, and the lowest level for any significant input determines leveling. These inputs are summarized in the three broad levels below:

Level 1 –

Unadjusted quoted prices in active markets for identical securities to which the Trust has access at the date of measurement.

Level 2 –

Other significant observable inputs (including quoted prices for similar or related securities in both active and inactive markets, interest rates, foreign exchange rates, and fair value estimates for foreign securities indices).

Level 3 –

Significant unobservable inputs to the extent observable inputs are unavailable (including the Funds’ own assumptions in determining fair value of investments based on the best available information).

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

The following table provides the fair value measurements of applicable Fund assets by level within the fair value hierarchy for each Fund as of October 31, 2022. These assets are measured on a recurring basis.


Fund	Description	Quoted prices in active markets for identical assets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total

Stock	Common Stocks⁽¹⁾	$	5,590,846,289	$	—	$	—	$	5,590,846,289
Fund	Short-Term Investments		211,502,114		—		—		211,502,114

	Total Investments in Securities	$	5,802,348,403	$	—	$	—	$	5,802,348,403


Growth	Common Stocks⁽¹⁾	$	6,781,911,254	$	—	$	—	$	6,781,911,254
Fund	Rights⁽²⁾		—		—		84,151		84,151
	Short-Term Investments		191,463,748		—		—		191,463,748

	Total Investments in Securities	$	6,973,375,002	$	—	$	84,151	$	6,973,459,153


Aggressive	Common Stocks⁽¹⁾	$	6,765,721,086	$	—	$	—	$	6,765,721,086
Growth	Preferred Stocks⁽³⁾		1,814,750		—		—		1,814,750
Fund	Warrants⁽⁴⁾		709,995		—		—		709,995
	Rights⁽²⁾		—		—		206,895		206,895
	Short-Term Investments		170,943,658		—		—		170,943,658

	Total Investments in Securities	$	6,939,189,489	$	—	$	206,895	$	6,939,396,384

⁽¹⁾

Refer to each Fund’s respective Schedule of Investments for the breakdown of major categories.

⁽²⁾

Health Care

⁽³⁾

Financials

⁽⁴⁾

Materials

Following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value.


Epizyme, Inc. - CVR (Issue Date 8/15/22)
	Growth Fund		Aggressive Growth Fund
Balance at October 31, 2021	$	—	$	—
Purchases (Received)		84,151		206,895
Sales (Proceeds)		—		—
Realized Gain (Loss)		—		—
Change in Unrealized Appreciation/Depreciation		—		—

Balance at October 31, 2022	$	84,151	$	206,895

During the year ended October 31, 2022, the Funds determined the fair value of Epizyme, Inc. (“Epizyme”) CVR considering available information, including the value of Epizyme stock prior to the issuance of the CVR. The likelihood of receiving payments pursuant to an agreement will depend on achievement of certain milestones.

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

(5) Distribution to Shareholders

Net investment income and net realized gains differ for financial statement and tax purposes due to differing treatments of deferred wash sale losses.

As of October 31, 2022, the components of capital on a tax basis were as follows:


	PRIMECAP Odyssey Stock Fund			PRIMECAP Odyssey Growth Fund			PRIMECAP Odyssey Aggressive Growth Fund
Cost of investments for tax purposes⁽¹⁾	$	3,323,509,538		$	3,973,725,721		$	4,586,591,584

Gross tax unrealized appreciation		2,790,740,603			3,557,621,010			3,544,311,611
Gross tax unrealized depreciation		(312,291,596	)		(558,179,002	)		(1,191,548,104	)

Net tax unrealized appreciation		2,478,449,007			2,999,442,008			2,352,763,507

Undistributed ordinary income		58,348,538			46,160,486			—
Undistributed long-term capital gain		553,003,672			706,868,322			640,274,263

Total distributable earnings		611,352,210			753,028,808			640,274,263

Other accumulated gain (loss)		—			—			(12,580,563	)

Total accumulated gain	$	3,089,801,217		$	3,752,470,816		$	2,980,457,207

⁽¹⁾

At October 31, 2022 the differences in the basis for federal income tax purposes and financial reporting purposes are due to the tax deferral of losses on wash sales.

U.S. GAAP requires that permanent book-to-tax differences be reclassified among the components of net assets. These reclassifications have no effect on net assets or NAV. For the fiscal year ended October 31, 2022, the following reclassifications were made:


	Undistributed Net Investment Gain (Loss)		Accumulated Net Realized Gain (Loss)		Paid In Capital
Stock Fund	$	(27,449)	$	(89,795,892)	$	89,823,341
Growth Fund	$	(84,221)	$	(117,059,635)	$	117,143,856
Aggressive Growth Fund	$	7,091,673	$	(125,642,491)	$	118,550,818

The Funds used a tax accounting practice to treat a portion of the price of capital shares redeemed during the year as distributions from net realized capital gains. The PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund reclassified $89,823,341, $117,143,856, and $118,550,818, respectively, from Accumulated Net Realized Gain to Paid In Capital. Other permanent book-to-tax differences that required reclassification among the Funds’ capital accounts related to foreign currency adjustments and net operating losses. The PRIMECAP Odyssey Aggressive Growth Fund deferred, on a tax basis, late-year ordinary losses of $12,580,563.

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

Tax components of dividends paid during the fiscal years ended October 31, 2022 and October 31, 2021 were as follows:


	October 31, 2022				October 31, 2021
	Ordinary Income Distributions		Long-Term Capital Gain Distributions		Ordinary Income Distributions		Long-Term Capital Gain Distributions
Stock Fund	$	56,748,200	$	606,583,489	$	91,207,885	$	430,738,717
Growth Fund	$	35,104,520	$	1,153,169,227	$	35,746,054	$	1,051,998,107
Aggressive Growth Fund	$	—	$	1,124,701,183	$	—	$	822,100,806

The Funds designated as long-term capital gain dividends, pursuant to IRC Section 852 (b) (3), the amounts necessary to reduce the earnings and profits of the Funds related to net capital gains to zero for the tax year ended October 31, 2022.

(6) Investment Advisory and Other Agreements

The Trust has entered into an investment management agreement with the Investment Advisor on behalf of each Fund. For its services to the Funds, the Investment Advisor receives an annual fee, payable on a quarterly basis, at the annual rate of 0.60% on the first $100 million of each Fund’s average daily assets, 0.55% on the next $9.9 billion of each Fund’s average daily net assets, and 0.50% on each Fund’s average daily assets in excess of $10 billion. For the year ended October 31, 2022, each Fund paid the Investment Advisor at an effective annual rate of 0.55% of its respective average net assets.

U.S. Bancorp Fund Services, LLC, d/b/a U.S. Bank Global Fund Services, serves as the administrator, fund accountant, and transfer agent to the Funds. U.S. Bank, N.A. serves as the Funds’ custodian. ALPS Distributors, Inc. serves as the Funds’ distributor.

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

(7) Other Affiliates

Certain of the Funds’ investments are in companies that are considered to be affiliated companies of a Fund because the Fund owns 5% or more of the outstanding voting securities of the company. With respect to each such investment, refer to each Fund’s respective Schedule of Investments for the information on the sector of each such company, the number of shares of each such company held, and the percentages of net assets represented by such companies held in each sector. Transactions during the period in securities of these companies were as follows:

PRIMECAP Odyssey Aggressive Growth Fund


			Current Period Transactions
Common Stock	Market Value at October 31, 2021		Purchases at Cost		Proceeds from Securities Sold		Dividend Income		Realized Gain (Loss)			Change in Unrealized Gain (Loss)			Market Value at October 31, 2022
Axcelis Technologies, Inc.⁽¹⁾	$	112,881,150	$	—	$	33,090,337	$	—	$	28,332,607		$	(20,355,210	)	$	N/A
Calithera Biosciences, Inc.		14,261,542		56,740		349,533		—		(9,018,520	)		(4,248,144	)		702,085
Cerus Corp.		65,404,680		—		3,863,780		—		29,730			(27,852,148	)		33,718,482
Epizyme, Inc.⁽¹⁾⁽²⁾		41,220,089		1,281,038		16,531,884		—		(142,996,515	)		117,027,272			N/A
Nektar Therapeutics		168,252,957		—		7,891,066		—		(3,792,013	)		(117,834,847	)		38,735,031
NN, Inc.⁽¹⁾		13,238,510		—		2,970,728		—		(13,325,146	)		7,291,260			N/A
Pulmonx Corp.		98,058,947		41,310,610		1,158,495		—		(2,816,596	)		(86,160,314	)		49,234,152
Rhythm Pharmaceuticals, Inc.		55,174,106		4,240,169		1,091,330		—		(3,847,741	)		71,792,115			126,267,319
ServiceSource International, Inc.⁽¹⁾⁽³⁾		8,838,960		—		10,150,635		—		(23,714,097	)		25,025,772			N/A
Standard BioTools, Inc.⁽⁴⁾		21,584,845		—		667,649		—		(3,615,686	)		(12,648,614	)		4,652,896
Wave Life Sciences Ltd.⁽¹⁾		17,762,290		62,348		297,683		—		(2,758,380	)		3,172,226			N/A
Xencor, Inc.		168,988,492		14,431,804		13,053,878		—		4,921,953			(52,124,295	)		123,164,076

Total	$	785,666,568	$	61,382,709	$	91,116,998	$	—	$	(172,600,404	)	$	(96,914,927	)	$	376,474,041

⁽¹⁾

No longer an affiliate as of October 31, 2022.

⁽²⁾

Included in “Proceeds from Securities Sold” are proceeds received when Epizyme, Inc. was acquired.

⁽³⁾

Included in “Proceeds from Securities Sold” are proceeds received when ServiceSource International, Inc. was acquired.

⁽⁴⁾

Formerly Fluidigm Corp. Name change effective April 6, 2022.

Notes to Financial Statements

PRIMECAP Odyssey Funds

For the Year Ended October 31, 2022 – continued

(8) Other Matters

Significant market disruptions, such as those caused by pandemics (e.g., COVID-19 pandemic), natural or environmental disasters, war (e.g., Russia’s invasion of Ukraine), acts of terrorism, or other events, can adversely affect local and global markets and normal market operations. The ultimate economic fallout from these disruptions and the long-term impact on economies, markets, industries, and individual issuers, are not known. The operational and financial performance of the issuers of securities in which each Fund invests depends on future developments and may negatively impact the value of each Fund’s investments and lead to losses.

(9) Subsequent Events

The Funds have evaluated subsequent events through the issuance of the financial statements and determined that no events have occurred that require disclosure.

Report of Independent Registered

Public Accounting Firm

To the Board of Trustees of PRIMECAP Odyssey Funds and Shareholders of

PRIMECAP Odyssey Stock Fund,

PRIMECAP Odyssey Growth Fund, and

PRIMECAP Odyssey Aggressive Growth Fund

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund (constituting PRIMECAP Odyssey Funds, hereafter collectively referred to as the “Funds”) as of October 31, 2022, the related statements of operations for the year ended October 31, 2022, the statements of changes in net assets for each of the two years in the period ended October 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended October 31, 2022 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of October 31, 2022, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended October 31, 2022 and each of the financial highlights for each of the five years in the period ended October 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of October 31, 2022 by correspondence with the custodian and brokers. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Los Angeles, California

December 13, 2022

We have served as the auditor of one or more investment companies in PRIMECAP Odyssey Funds Investment Company Complex since 2004.

Expense Example

PRIMECAP Odyssey Funds

(Unaudited)

As a shareholder of one or more of the Funds, you incur ongoing costs including management fees and other Fund expenses. This expense example is intended to help you understand your ongoing costs (in dollars) of investing in the Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

The expense example is based on an investment of $1,000 invested for a six-month period beginning May 1, 2022 through October 31, 2022.

Actual Expenses

The information in the table adjacent to the heading “Actual Performance” provides actual account values and actual expenses. You may use the information in these columns, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the column entitled “Expenses Paid during Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

The information in the table adjacent to the heading “Hypothetical Performance (5% return before expenses)” provides hypothetical account values and hypothetical expenses based on the Funds’ actual expense ratios and an assumed rate of return of 5% per year before expenses, which are not the Funds’ actual returns. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Funds and other mutual funds. To do so, compare these 5% hypothetical examples with the 5% hypothetical examples that appear in the shareholder reports of the other mutual funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only. Therefore, the information adjacent to the heading “Hypothetical Performance (5% return before expenses)” is useful in comparing ongoing costs only and will not help you determine the relative total costs of owning different mutual funds. In addition, if transactional costs were included, your costs would have been higher.

Expense Example

PRIMECAP Odyssey Funds

(Unaudited) – continued


	Beginning Account Value (5/1/22)		Ending Account Value (10/31/22)		Expenses Paid During Period⁽¹⁾ (5/1/22 to 10/31/22)		Expense Ratio During Period⁽¹⁾(5/1/22 to 10/31/22)
PRIMECAP Odyssey Stock Fund
Actual Performance	$	1,000.00	$	960.00	$	3.26		0.66%
Hypothetical Performance (5% return before expenses)	$	1,000.00	$	1,021.88	$	3.36		0.66%
PRIMECAP Odyssey Growth Fund
Actual Performance	$	1,000.00	$	957.20	$	3.26		0.66%
Hypothetical Performance (5% return before expenses)	$	1,000.00	$	1,021.88	$	3.36		0.66%
PRIMECAP Odyssey Aggressive Growth Fund
Actual Performance	$	1,000.00	$	932.20	$	3.17		0.65%
Hypothetical Performance (5% return before expenses)	$	1,000.00	$	1,021.93	$	3.31		0.65%

⁽¹⁾

Expenses are equal to a Fund’s annualized expense ratio as indicated, multiplied by the average account value over the period, multiplied by the number of days in the most recent fiscal half-year period (184), then divided by the number of days in the fiscal year (365) to reflect the one-half year period.

Additional Information

PRIMECAP Odyssey Funds

(Unaudited)

Additional Tax Information

PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund designate 100%, 100%, and 0%, respectively, of ordinary income distributions paid during the fiscal year ended October 31, 2022 as qualified dividend income.

PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive Growth Fund designate 12.63%, 69.22%, and 0%, respectively, of ordinary income distributions paid during the fiscal year ended October 31, 2022 as short-term capital gain under Internal Revenue Code 871(k)(2)(C).

Proxy Voting Procedures

The Investment Advisor votes proxies relating to portfolio securities in accordance with procedures that have been approved by the Trust’s Board of Trustees. You may obtain a description of these procedures, free of charge, by calling toll-free 1-800-729-2307. This information is also available through the Securities and Exchange Commission’s (“SEC”) website at www.sec.gov.

Proxy Voting Record

Information regarding how the Funds voted proxies relating to the portfolio securities during the most recent 12-month period ended June 30 is available, without charge, by calling toll-free 1-800-729-2307. This information is also available through the SEC’s website at www.sec.gov.

Portfolio Holdings Disclosure

The Funds file a complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Part F of Form N-PORT. This information is available, without charge, by calling toll-free 1-800-729-2307. The Funds’ Part F of Form N-PORT is also available on the SEC’s website at www.sec.gov. The Funds’ Part F of Form N-PORT may be reviewed and copied at the Commission’s Public Reference Room in Washington, DC, and information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330.

Board Approval of the Renewal of the Investment Advisory Agreement

The Board of Trustees (the “Board”) of PRIMECAP Odyssey Funds (the “Trust”) is comprised of seven Trustees, six of whom are not “interested persons” of the Trust as defined by the Investment Company Act of 1940, as amended (the “Independent Trustees”). In October 2022, the Board of Trustees, including the Independent Trustees, approved a one-year renewal of the Trust’s investment advisory agreement with PRIMECAP Management Company (the “Advisor”) with respect to the series of the Trust (the “Funds”).

General Information

As part of the annual contract review process, the Independent Trustees, through counsel to the Trust and the Independent Trustees, requested and received extensive materials, including

Additional Information

PRIMECAP Odyssey Funds

(Unaudited) – continued

information related to the nature, extent, and quality of the services provided to the Funds by the Advisor; information prepared by Broadridge Financial Solutions (“Broadridge”) comparing the performance and risk profile of each Fund to those of relevant market indices and of other funds in the relevant Morningstar, Inc. (“Morningstar”) categories and in a smaller group of funds selected by Broadridge; information prepared by Broadridge comparing the advisory fees and total expenses to those of other funds in the relevant Morningstar category and peer group; financial information for the Advisor and information related to the profitability to the Advisor of the investment advisory agreement with the Trust; the extent to which the Advisor expects to achieve economies of scale in connection with the services it provides to each Fund; any ancillary or “fall out” benefits that the Advisor may derive from its relationship with the Funds; and the personnel of the Advisor providing services to the Funds. The Independent Trustees also requested and received information regarding the Advisor’s risk controls, risk evaluation processes, compliance program (including brokerage and trading processes), information technology infrastructure (including cyber security measures), business continuity plans, and other matters.

The Trust engaged Broadridge to prepare an independent expense and performance analysis for each Fund. In performing its analyses, Broadridge used data compiled by Morningstar to compare the expenses and performance of each Fund to those of similar funds managed by other advisors identified by Broadridge. The Board reviewed the Broadridge materials, which included information regarding the performance of each Fund compared with the performance of its benchmark index and of the entire universe of funds in its Morningstar retail category, as well as the performance of a group of comparable funds selected by Broadridge from the relevant Morningstar category (each a “Peer Group”), for the one-, three-, five- and ten-year periods ended July 31, 2022 (in each case net of fees); as well as information regarding the advisory fees paid to the Advisor and the total expense ratio of each Fund compared to those of a peer group of comparable funds selected by Broadridge (each an “Expense Peer Group”) from the Fund’s Morningstar retail category.

With respect to investment performance, the Trustees noted that the Advisor had made quarterly presentations to the Board regarding the Funds’ portfolio construction, investment strategies, and results. The Trustees also noted that in addition to meeting with the Funds’ portfolio managers on a quarterly basis, they also received presentations from different investment analysts throughout the year on specific investment sectors and each Fund’s investments in those sectors. In considering the renewal of the agreement, the Board also took into account other information it had received at past Board and committee meetings with respect to various matters.

The Trustees reviewed information from counsel to the Trust and the Independent Trustees regarding their responsibilities in considering whether to renew the investment advisory agreement for an additional one-year period. In connection with their deliberations, the Board considered such information and factors that they believed to be relevant. The Board considered renewal of the investment advisory agreement separately for each Fund, although the Board took into account the common interests of all the Funds in its review. In considering these matters, the Board discussed the renewal of the investment advisory agreement with management, and the Independent Trustees met in a private session with counsel to the Trust and the Independent Trustees at which no employees of the Advisor were present.

Additional Information

PRIMECAP Odyssey Funds

(Unaudited) – continued

In deciding to approve the renewal of the investment advisory agreement, the Board and the Independent Trustees did not identify a single factor that was controlling. The Board and the Independent Trustees concluded that each of the various factors referred to below favored such approval. The following summary describes the key factors considered by the Trustees and their conclusions that formed the basis for approving the renewal of the investment advisory agreement in light of the legal advice furnished by counsel and their own business judgment. This summary is not inclusive of all of the factors considered, and each Trustee did not necessarily attribute the same weight to each factor.

Nature, Extent, and Quality of Services

The Board considered the services provided by the Advisor to the Funds under the investment advisory agreement, including the background, education, and experience of the Advisor’s key portfolio management, compliance, and operational personnel; its overall financial strength and stability; its resources and efforts to retain, attract, and motivate capable personnel to serve the Funds; and the overall general quality and depth of its organization. The Board also took into account the experience, capability, and integrity of the Advisor’s senior management, the time that senior management commits to the Funds, and the Advisor’s demonstrated commitment to the Funds; its investment philosophy and processes, including its brokerage and trading practices; its disaster recovery and contingency planning; its oversight of the Funds’ internal control environment with regard to compliance with applicable laws and regulations; and the significant investment by each portfolio manager in the Funds that he manages, which helps align his interests with those of Fund shareholders. The Trustees concluded that the nature, extent, and quality of services provided under the investment advisory agreement were of a high level and satisfactory.

Investment Performance

The Board assessed the performance of each Fund compared with the performance of its benchmark(s) and other funds in the Fund’s Morningstar retail category and Peer Group for the one-, three-, five- and ten-year periods ended July 31, 2022. The Board made the following observations in reviewing the Funds’ performance:

•

The annualized total return of the PRIMECAP Odyssey Stock Fund outperformed the S&P 500^® Index for the since inception period ended July 31, 2022, but underperformed compared to the Index for the one-, three-, five-, and ten-year periods by 1.67%, 3.03%, 2.64% and 0.67%, respectively. The Fund’s return exceeded the median of funds in the Morningstar Large Relative Value category for the ten-year period by 0.45% but was below the median returns of the Morningstar category for the one-, three- and five-year periods by 0.64%, 1.47% and 1.04%, respectively. The Fund’s returns were above the median of the Peer Group for the one- and ten-year periods by 0.26% and 0.30%, respectively, but were below the median of the Peer group for the three- and five-year periods by 0.85% and 0.02%, respectively.

•

The annualized total returns of the PRIMECAP Odyssey Growth Fund outperformed its primary benchmark, the S&P 500^® Index, for the since inception period ended July 31, 2022, but underperformed compared to the Index for the one-, three-, five- and ten-year

Additional Information

PRIMECAP Odyssey Funds

(Unaudited) – continued

periods by 6.45%, 4.38%, 2.53% and 0.12%, respectively. The Fund’s annualized total returns outperformed its secondary benchmark, the Russell 1000 Growth Index, for the one-year period by 0.84%, but underperformed relative to the Index for the three-, five-, ten-year and since inception periods by 7.07%, 6.00%, 2.27% and 0.65%, respectively. The Fund outperformed the medians of funds in the Morningstar Large Core Growth category and Peer Group for the one-year period. For the three-, five- and ten-year periods, the Fund’s annualized total returns were below the Morningstar category’s median return by 3.50%, 3.03% and 0.31%, respectively. The Fund’s annualized total returns were below the median returns of the Peer Group for the three-, five- and ten-year periods by 3.22%, 3.82%, and 0.75%, respectively.

•

The annualized total returns of the PRIMECAP Odyssey Aggressive Growth Fund were above the returns of the Fund’s primary benchmark, the S&P 500^® Index, and its secondary benchmark, the Russell Mid Cap Growth Index, for the ten-year and since inception periods ended July 31, 2022. The Fund’s annualized total return was below the return of the S&P 500^® Index for the one-, three- and five-year periods by 15.98%, 8.21% and 4.57%, respectively. The Fund’s annualized total returns for the one- and ten-year periods were above the returns of the Russell Mid Cap Growth Index by 1.14% and 1.44%, respectively, but below the three- and five-year periods by 2.36% and 2.80%, respectively. For the ten-year period, the Fund’s performance was above the median of funds in the Morningstar All Cap Growth category and Peer Group by 1.89% and 1.41%, respectively. For the one-, three- and five-year periods, the Fund returned 0.11%, 3.41% and 2.84% less than the category median, respectively. The Fund’s annualized total return for the one-year period was equal to the median of the Peer Group but was lower than the Peer Group medians for the three- and five-year periods by 3.46% and 2.89%, respectively.

In assessing the performance of the Funds, the Trustees considered the Advisor’s explanation that the Funds’ performance struggled to keep pace with that of their respective indices, Peer Groups, and Morningstar categories as the Advisor stayed committed to its investment philosophy and refused to chase momentum driven stocks during the height of the COVID-19 pandemic. The Board considered the Advisor’s explanation that the Funds’ performance was negatively impacted by a confluence of factors that worked against the Funds’ investment objectives and risk profiles during the COVID-19 pandemic, including: the Funds’ underweight positions in the “Big 5” tech stocks (Microsoft, Apple, Amazon, Alphabet, and Meta), since those companies benefited significantly from the pandemic; the Funds’ overweight positions in the airline and cruise line industries when the pandemic first began; and delays and cancellation of medical elective procedures, which negatively impacted the healthcare devices sector. The Board also considered that the Advisor feels the Funds are well positioned for the future as consumers are expected to rotate back to services such as air travel and cruises and the healthcare industry is expected to develop more drugs and treatments to address significant unmet medical needs. The Trustees noted that the Advisor believes that each Fund continues to hold considerable value in its portfolio despite the various periods of underperformance. The Trustees also noted that each Fund had performed well over the long term.

Additional Information

PRIMECAP Odyssey Funds

(Unaudited) – continued

Based on the information provided to them and in consideration of the specific investment objectives and risk profiles of each Fund, the Board and the Independent Trustees concluded that the performance of each Fund was satisfactory.

Advisory Fees and Fund Expenses

The Board reviewed the advisory fees and expenses paid by each Fund compared to those of other funds in the same Morningstar retail category (for the Stock Fund – Large Blend funds; for the Growth Fund – Large Growth funds; and for the Aggressive Growth Fund – Mid-Cap Growth funds), and of other funds in the Fund’s Expense Peer Group, which was selected by Broadridge and was comprised of funds comparable to the Fund with fee structures and characteristics similar to those of the Funds (e.g., no distribution or shareholder servicing fees, and excluding load funds, index and enhanced index funds, funds of funds, and multi-manager funds).

The materials for the meeting indicated as follows:

•

The advisory fee of the Stock Fund was the same as the medians of the Fund’s Expense Peer Group and the funds in the Morningstar Large Blend retail category.

•

The advisory fee of the Growth Fund was below the median fees of the funds in the Morningstar Large Growth category and the Fund’s Expense Peer Group.

•

The advisory fee of the Aggressive Growth Fund was below the median fees of the funds in the Morningstar Mid-Cap Growth category and the Fund’s Expense Peer Group.

•

The total expense ratios of the Stock Fund, the Growth Fund and the Aggressive Growth Fund were below the medians of the respective Expense Peer Groups and Morningstar retail categories.

The Board also reviewed the fees charged by the Advisor to other clients, including other mutual funds for which it provides sub-advisory services. The Board considered that although those fees were lower than those charged by the Advisor to the Funds, the differences appropriately reflected the investment, operational, and regulatory differences between advising other clients and the Funds, noting that mutual funds are subject to certain requirements under the 1940 Act that do not apply to the Advisor’s separate account clients. The Trustees considered the services provided by the Advisor under the Investment Advisory Agreement, including providing the Chief Compliance Officer, certain other officers of the Trust and other personnel involved in the oversight of the Trust’s service providers. The Board further noted that the advisory fee was the sole source of revenue from the Funds to the Advisor. The Board and the Independent Trustees determined that the advisory fees and expenses charged to the Funds were reasonable in consideration of the services provided.

Costs and Profits of the Advisor

The Board reviewed information regarding the Advisor’s financial position and concluded that the Advisor would be able to continue to provide advisory services to the Funds. The Board also reviewed information relating to the Advisor’s profitability. The Board recognized the competitiveness of the registered fund industry and the importance of an investment advisor’s

Additional Information

PRIMECAP Odyssey Funds

(Unaudited) – continued

long-term profitability, including for maintaining management stability and accountability. The Board noted that the Advisor had closed the Aggressive Growth Fund in January 2014 to most new investors, limiting the growth of the Fund and consequently future profits to the Advisor as it relates to the Fund. In considering the Advisor’s profitability, the Trustees recognized the importance of the profitability of the Advisor, not only in maintaining its own financial condition, but also in maintaining an environment in which it is able to attract and retain talented investment professionals. Recognizing the difficulty in evaluating an investment advisor’s profitability with respect to the funds it manages in the context of an advisor with multiple lines of business, and noting that other profitability methodologies might also be reasonable, the Board and the Independent Trustees concluded that the profit of the Advisor from its relationship with each Fund was reasonable.

Economies of Scale and Other Benefits to the Investment Advisor

The Trustees considered that the Investment Advisory Agreement provides fee breakpoints at $100 million and $10 billion in assets for each Fund, that the Advisor had added the $10 billion breakpoint effective May 1, 2021, and that that the fees continued to compare favorably to those of other actively managed funds with similar investment objectives. The Board considered that the Advisor had significant assets under management at the time the Funds commenced operations and that the Funds were offered advisory fee rates at inception that reflected scale within the Advisor’s business. The Board also acknowledged various diseconomies of scale experienced by the Advisor as the Funds have grown, including the hiring of additional personnel and the provision of additional services to the Funds including online access to shareholder accounts and improved technology, systems, and hardware. The Board and the Independent Trustees concluded that the Advisor had shared any economies of scale it had realized from the Funds with the Funds and their shareholders through advisory fee breakpoints, the hiring of additional personnel, and the provision of additional services to the Funds.

The Board also considered the benefits received by the Advisor as a result of its relationship with the Funds other than investment advisory fees, including any research provided to the Advisor by broker-dealers providing execution services to the Funds, the intangible benefits of the Advisor’s association with the Funds generally, and any favorable publicity arising in connection with the Funds’ performance.

Conclusions

Based on their review, including their consideration of each of the factors referred to above, the Board and the Independent Trustees concluded that the compensation payable to the Advisor pursuant to the investment advisory agreement with respect to each Fund was fair and reasonable in light of the services being provided by the Advisor to the Fund and its shareholders and that renewal of the investment advisory agreement with respect to each Fund was in the best interest of the Fund and its shareholders.

Management

PRIMECAP Odyssey Funds

(Unaudited)

Portfolio Managers

PRIMECAP Management Company has five portfolio managers who together have more than 150 years of investment experience. The portfolio managers primarily responsible for overseeing the Funds’ investments are:


Name	Years of Experience
Theo A. Kolokotrones		52
Joel P. Fried		37
Alfred W. Mordecai		25
M. Mohsin Ansari		22
James Marchetti		17

Each of these five individuals manages a portion of the PRIMECAP Odyssey Stock Fund, the PRIMECAP Odyssey Growth Fund, and the PRIMECAP Odyssey Aggressive Growth Fund. A portion of each Fund’s assets may be managed by individuals in the Investment Advisor’s research department.

Officers and Trustees

The Trust’s officers, who oversee the Funds’ daily operations, are appointed by the Board of Trustees. The trustees are responsible for the overall management of the Trust, including establishing the Funds’ policies and general supervision and review of their investment activities. The Statement of Additional Information includes additional information about the trustees and is available, without charge, by calling 1-800-729-2307 or at the Funds’ website at www.primecap.com.

Executive Officers. The table below sets forth certain information about each of the Trust’s executive officers. The address for each officer is 177 East Colorado Boulevard, 11^th Floor, Pasadena, CA 91105.


Name Age	Position(s) Held with Trust	Term of Office; Length of Time Served	Principal Occupation(s) During Past 5 Years
Theo A. Kolokotrones Age: 76	Co-Chief Executive Officer	Indefinite; Since 09/04	Chairman, Director, and Portfolio Manager PRIMECAP Management Company
Joel P. Fried Age: 60	Co-Chief Executive Officer and Trustee	Indefinite; Since 09/04	President, Director, and Portfolio Manager PRIMECAP Management Company

Management

PRIMECAP Odyssey Funds

(Unaudited) – continued


Name Age	Position(s) Held with Trust	Term of Office; Length of Time Served	Principal Occupation(s) During Past 5 Years
Alfred W. Mordecai Age: 55	Co-Chief Executive Officer	Indefinite; Since 10/12	Vice Chairman, Director, and Portfolio Manager PRIMECAP Management Company
Michael J. Ricks Age: 44	Chief Financial Officer, Secretary, Chief Administrative Officer	Indefinite; Since 03/11	Director of Fund Administration PRIMECAP Management Company; Chief Compliance Officer, PRIMECAP Odyssey Funds; Chief Compliance Officer PRIMECAP Management Company March 2019-March 2020
Jennifer Ottosen Age: 62	Chief Compliance Officer, AML Compliance Officer	Indefinite; Since 02/20	Chief Compliance Officer, PRIMECAP Management Company since March 2020; Senior Compliance Officer, PRIMECAP Management Company May 2019-March 2020; CCO Dividend Assets Capital, LLC; CCO & General Counsel, GW Capital, Inc.

“Independent” Trustees. The table below sets forth certain information about each of the trustees of the Trust who is not an “interested person” of the Trust as defined in the 1940 Act (“Independent Trustees”). The address for each Independent Trustee is 177 East Colorado Boulevard, 11^th Floor, Pasadena, CA 91105.


Name Age	Position(s) Held with Trust	Term of Office; Length of Time Served	Principal Occupation(s) During Past 5 Years	Number of Portfolios in Fund Complex Overseen by Trustee⁽¹⁾	Other Director- ships Held by Trustee
Benjamin F. Hammon Age: 87	Chairman of the Board and Trustee	Indefinite; Since 09/04	Retired; Private investor	3	None
Wayne H. Smith Age: 81	Chairman of the Audit Committee and Trustee	Indefinite; Since 09/04	Retired; Private investor	3	None
Joseph G. Uzelac Age: 78	Trustee	Indefinite; Since 10/07	Retired; Private investor	3	None
Elizabeth D. Obershaw Age: 62	Trustee	Indefinite; Since 06/08	Retired; Formerly, Managing Director, Horsley Bridge Partners, an investment advisor (2007-2021)	3	None
J. Blane Grinstead Age: 67	Trustee	Indefinite; Since 03/19	Retired; Private investor	3	Orenda, Inc., a renewable energy technology company (May 2020 – Present)
Michael Glazer Age: 82	Trustee	Indefinite; Since 10/19	Retired; Formerly, Partner and Senior Counsel, Morgan, Lewis & Bockius LLP	3	None

⁽¹⁾

Fund Complex includes any funds, series of funds, or trusts that share the same advisor or that hold themselves out to investors as related companies.

Management

PRIMECAP Odyssey Funds

(Unaudited) – continued

“Interested” Trustee. The table below sets forth certain information about the trustee of the Trust who is an “interested person” of the Trust as defined by the 1940 Act. The address for the interested trustee is 177 East Colorado Boulevard, 11^th Floor, Pasadena, CA 91105.

Name
Age

Position(s)
Held
with Trust

Term of
Office;
Length of
Time Served

Principal Occupation(s)

During Past 5 Years

Number of
Portfolios in
Fund Complex
Overseen by
Trustee⁽¹⁾

Other
Director-
ships Held
by Trustee

Joel P. Fried⁽²⁾

Age: 60

Co-Chief Executive Officer and Trustee

Indefinite;
Since 09/04

President, Director, and Portfolio Manager
PRIMECAP Management Company

None

⁽¹⁾

Fund Complex means two or more registered investment companies that hold themselves out to investors as related companies for purposes of investment and investor services or have a common investment advisor or have an investment advisor that is an affiliated person of the investment advisor of any of the other registered investment companies.

⁽²⁾

Mr. Fried is an “interested person” of the Trust, as defined by the 1940 Act, because of his employment with PRIMECAP Management Company, the investment advisor to the Trust.

Privacy Notice

PRIMECAP Odyssey Funds

PRIMECAP Management Company

Maintaining the confidentiality of client personal financial information is very important to PRIMECAP Odyssey Funds (the “Trust”) and PRIMECAP Management Company (the “Advisor”). The Advisor and the Trust may collect several types of nonpublic personal information about investors, including:

•

Information from forms that investors may fill out and send to the Advisor or the Trust in connection with an account (such as name, address, and social security number).

•

Information an investor may give the Advisor or the Trust orally.

•

Information about the amount investors have invested in an account.

•

Information about any bank account investors may use for transfers between a bank account and a shareholder account.

The Advisor and the Trust will not sell or disclose client personal information to anyone except as permitted or required by law. For example, information collected may be shared with the independent auditors in the course of the annual audit of the Advisor or the Trust. The Advisor or the Trust may also share this information with the Advisor’s or the Trust’s legal counsel, as deemed appropriate, and with regulators. Finally, the Advisor or the Trust may disclose information about clients or investors at the client’s or investor’s request (for example, by sending duplicate account statements to someone designated by the client or investor), or as otherwise permitted or required by law.

Within the Advisor and the Trust, access to information about clients and investors is restricted to those employees or service providers who need to know the information to service client accounts. The Advisor’s employees are trained to follow its procedures to protect client privacy and are instructed to access information about clients only when they have a business reason to obtain it.

The Advisor and the Trust reserve the right to change this privacy policy in the future, but we will not disclose investor nonpublic personal information except as required or permitted by law without giving the investor an opportunity to instruct us not to do so.

Investment Advisor

PRIMECAP MANAGEMENT COMPANY

177 East Colorado Boulevard, 11th Floor

Pasadena, California 91105

•

Distributor

ALPS DISTRIBUTORS, INC.

1290 Broadway, Suite 1000

Denver, Colorado 80203

•

Custodian

U.S. BANK, N.A.

1555 North RiverCenter Drive, Suite 302

Milwaukee, Wisconsin 53212

•

Transfer Agent

U.S. BANCORP FUND SERVICES, LLC

615 East Michigan Street, 3rd Floor

Milwaukee, Wisconsin 53202

•

Administrator

U.S. BANCORP FUND SERVICES, LLC

2020 East Financial Way, Suite 100

Glendora, California 91741

•

Legal Counsel

MORGAN, LEWIS & BOCKIUS LLP

600 Anton Boulevard, Suite 1800

Costa Mesa, California 92626

•

Independent Registered Public Accounting Firm

PRICEWATERHOUSECOOPERS LLP

601 South Figueroa Street, Suite 900

Los Angeles, California 90017

This report is intended for the shareholders of the PRIMECAP Odyssey Funds and may not be used as sales literature unless preceded or accompanied by a current prospectus.

Past performance results shown in this report should not be considered a representation of future performance. Share price and returns will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are dated and are subject to change.

PRIMECAP, PRIMECAP Odyssey, and the PRIMECAP Odyssey logo are trademarks of PRIMECAP Management Company.

(b) Not applicable.

Item 2. Code of Ethics.

The registrant has adopted a code of ethics that applies to the registrant’s principal executive officers and principal financial officer. The registrant has not made any amendments to its code of ethics during the period covered by this report. The registrant has not granted any waivers from any provisions of the code of ethics during the period covered by this report.

The registrant undertakes to provide to any person without charge, upon request, a copy of its code of ethics by mail when such person calls the registrant at 1-800-729-2307.

Item 3. Audit Committee Financial Expert.

The registrant’s Board of Trustees has determined that there is at least one audit committee financial expert serving on its audit committee. Wayne Smith is the registrant’s “audit committee financial expert” and is considered to be “independent” as each term is defined in Item 3 of Form N-CSR.

Item 4. Principal Accountant Fees and Services.

The registrant has engaged its principal accountant, PricewaterhouseCoopers LLP, to perform audit services, audit-related services, and tax services during the past two fiscal years. “Audit services” refer to performing an audit of the registrant’s annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years. “Audit-related services” refer to the assurance and related services by the principal accountant that are reasonably related to the performance of the audit. “Tax services” refer to professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning and specifically relate to the accountant’s review of the registrant’s federal and state tax returns. There were no other services provided by the principal accountant to the registrant during the past two fiscal years. The following table details the aggregate fees billed or expected to be billed to the registrant for each of the last two fiscal years for audit fees, audit-related fees, tax fees and other fees by the principal accountant.


	FYE 10/31/2022		FYE 10/31/2021
(a) Audit Fees	$	156,071	$	142,888
(b) Audit-Related Fees	$	0	$	0
(c) Tax Fees	$	18,927	$	17,526
(d) All Other Fees	$	0	$	0

(e)(1) The audit committee has adopted pre-approval policies and procedures that require the audit committee to pre-approve all audit and non-audit services of the registrant, including services provided to any entity affiliated with the registrant. All services were pre-approved and no waivers to the pre-approval requirement were made.

(e)(2) The percentage of fees billed by PricewaterhouseCoopers applicable to non-audit services pursuant to waiver of pre-approval requirement were as follows:


	FYE 10/31/2022			FYE 10/31/2021
Audit-Related Fees		0	%		0	%
Tax Fees		0	%		0	%
All Other Fees		0	%		0	%

(f) All of the principal accountant’s hours spent on auditing the registrant’s financial statements were attributed to work performed by full-time permanent employees of the principal accountant.

(g) The following table indicates the non-audit fees billed or expected to be billed by the registrant’s accountant for services to the registrant and to the registrant’s investment adviser (and any entity controlling, controlled by, or under common control with the investment adviser) for the last two years.


Non-Audit Related Fees	FYE 10/31/2022		FYE 10/31/2021
Registrant	$	18,927	$	17,526
Registrant’s Investment Adviser	$	0	$	0

(h) The audit committee of the board of trustees/directors has considered whether the provision of non-audit services that were rendered to the registrant’s investment adviser is compatible with maintaining the principal accountant’s independence and has concluded that the provision of such non-audit services by the accountant has not compromised the accountant’s independence.

(i) Not applicable.

(j) Not applicable.

Item 5. Audit Committee of Listed Registrants.

Not applicable to registrants who are not listed issuers (as defined in Rule 10A-3 under the Securities Exchange Act of 1934).

Item 6. Investments.

(a)	The registrant’s Schedule of Investments is included as part of the report to shareholders filed under Item 1 of this Form.

(b)	Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable to open-end investment companies.

Item 10. Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of trustees.

Item 11. Controls and Procedures.

(a)

The Registrant’s Co-Chief Executive Officers and Chief Financial Officer have reviewed the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “Act”)) as of a date within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934. Based on their review, such officers have concluded that the disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by others within the Registrant and by the Registrant’s service provider.

(b)

There were no changes in the Registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable to open-end investment companies.

Item 13. Exhibits.

(a)	(1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an exhibit. Incorporated by reference to the Registrant’s Form N-CSR filed July 7, 2022.

(2) A separate certification for each principal executive and principal financial officer pursuant to Rule 30a-2(a) under the Act (17 CFR 270.30a-2(a)). Filed herewith.

(3) Any written solicitation to purchase securities under Rule 23c-1 under the Act sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons. Not applicable to open-end investment companies.

(4) Change in the registrant’s independent public accountant. There was no change in the registrant’s independent public accountant for the period covered by this report.

(b)

Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


PRIMECAP Odyssey Funds

By		/s/ Joel P. Fried
		Joel P. Fried, Co-Chief Executive Officer

Date		December 21, 2022

By		/s/ Theo A. Kolokotrones
		Theo A. Kolokotrones, Co-Chief Executive Officer

Date		December 21, 2022

By		/s/ Alfred W. Mordecai
		Alfred W. Mordecai, Co-Chief Executive Officer

Date		December 21, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


By		/s/ Joel P. Fried
		Joel P. Fried, Co-Chief Executive Officer

Date		December 21, 2022

By		/s/ Theo A. Kolokotrones
		Theo A. Kolokotrones, Co-Chief Executive Officer

Date		December 21, 2022

By		/s/ Alfred W. Mordecai
		Alfred W. Mordecai, Co-Chief Executive Officer

Date		December 21, 2022

By		/s/ Michael J. Ricks
		Michael J. Ricks, Chief Financial Officer

Date		December 21, 2022

EX-99.CERT 2 d419919dex99cert.htm EX-99.CERT EX-99.CERT

EX.99.CERT

CERTIFICATIONS

I, Joel P. Fried, certify that:

1.	I have reviewed this report on Form N-CSR of PRIMECAP Odyssey Funds;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officers and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX.99.CERT

CERTIFICATIONS

I, Theo A. Kolokotrones, certify that:

1.	I have reviewed this report on Form N-CSR of PRIMECAP Odyssey Funds;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officers and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX.99.CERT

CERTIFICATIONS

I, Alfred W. Mordecai, certify that:

1.	I have reviewed this report on Form N-CSR of PRIMECAP Odyssey Funds;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officers and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX.99.CERT

CERTIFICATIONS

I, Michael J. Ricks, certify that:

1.	I have reviewed this report on Form N-CSR of PRIMECAP Odyssey Funds;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officers and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-99.906CERT 3 d419919dex99906cert.htm EX-99.906CERT EX-99.906CERT

EX.99.906CERT

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of the PRIMECAP Odyssey Funds does hereby certify, to such officer’s knowledge, that the report on Form N-CSR of the PRIMECAP Odyssey Funds for the year ended October 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as applicable, and that the information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the PRIMECAP Odyssey Funds for the stated period.


/s/ Joel P. Fried
Joel P. Fried Co-Chief Executive Officer, PRIMECAP Odyssey Funds

Dated:		December 21, 2022

/s/ Theo A. Kolokotrones
Theo A. Kolokotrones Co-Chief Executive Officer, PRIMECAP Odyssey Funds

Dated:		December 21, 2022

/s/ Alfred W. Mordecai
Alfred W. Mordecai Co-Chief Executive Officer, PRIMECAP Odyssey Funds

Dated:		December 21, 2022

/s/ Michael J. Ricks
Michael J. Ricks Chief Financial Officer, PRIMECAP Odyssey Funds

Dated:		December 21, 2022

This statement accompanies this report on Form N-CSR pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed as filed by PRIMECAP Odyssey Funds for purposes of the Securities Exchange Act of 1934.

GRAPHIC 4 g419919art_02pro.jpg GRAPHIC begin 644 g419919art_02pro.jpg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end GRAPHIC 5 g419919art_04pro.jpg GRAPHIC begin 644 g419919art_04pro.jpg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end GRAPHIC 6 g419919g00a03.jpg GRAPHIC begin 644 g419919g00a03.jpg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end GRAPHIC 7 g419919g00a05.jpg GRAPHIC begin 644 g419919g00a05.jpg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�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end GRAPHIC 8 g419919g00a07.jpg GRAPHIC begin 644 g419919g00a07.jpg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�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end